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Abstract  
 
       The factors governing maintenance of the non-renewable reservoir of primordial 
follicles in female mammals remain largely elusive. During the early stages of fetal 
development, oocytes grow in nests or clusters known as germ cell cysts. Cysts break 
down into individual oocytes in the perinatal period and become enclosed by somatic 
pregranulosa cells to form primordial follicles. Steroid hormones have been shown by 
numerous studies to be one of the important factors which critically govern the process of 
cyst breakdown and follicle formation. There has been earlier evidence from this 
laboratory to indicate that exogenous exposure of neonatal mice ovaries to estradiol (E2), 
progesterone (P4) or E2 mimicking chemicals known as xenoestrogens such as 
Diethylstilbestrol (DES) and Bisphenol-A (BPA) delay cyst breakdown and follicle 
formation. The overall goal of this dissertation project is centered on the pivotal question: 
“What is the source of steroid hormone signaling and its role in meiotic progression 
during fetal oocyte development in mice?” One of the two objectives of this dissertation 
was to identify the sources of the steroid hormones (maternal circulation or fetal ovaries) 
which regulate fetal oogenesis. Our studies showed prominent expression of both mRNA 
and protein in the fetal ovaries for aromatase and 3-beta-hydroxysteroid dehydrogenase 
(3βHSD), cardinal steroidogenic enzymes required for E2 and P4 synthesis respectively. 
The mRNA levels for both aromatase and 3βHSD in the fetal ovaries detected by qPCR 
were found to decrease prior to cyst breakdown. These results align to our previous 
model that high levels of steroid hormones keep oocytes in cysts during fetal 
development and the drop in hormone levels is required to trigger cyst breakdown. To 
	  
	  
	  
analyze the functional significance of this local steroid action, we used aromatase and 
3βHSD inhibitors (letrozole and trilostane respectively) in organ culture to block 
hormone production by fetal ovaries. We find that the total number of oocytes was 
reduced in treated ovaries compared to controls. The second objective of the dissertation 
was to examine the relation between two temporal events in mice oogenesis: progression 
to the diplotene stage and primordial follicle formation. We performed a thorough 
quantitative analysis by nuclear morphological observations of diplotene versus pre-
diplotene nuclei of hematoxylin and eosin stained serial sections of ovaries at different 
ages. Interestingly, we observed that primordial follicle formation occurs irrespective of 
the meiotic stage of the oocyte nuclei. Thus oocytes in follicles were found both at 
diplotene and pre-diplotene stages. We also wanted to understand the role of steroid 
hormone signaling in meiotic progression of oocytes. Our data indicate that exogenous 
treatment of P4 and not E2 decrease the number of follicles containing oocytes at 
diplotene. Such insights from the murine research models significantly contribute to our 
knowledge of the meiotic defects caused due to E2 or P4 exposure during fetal oogenesis 
in the case of human pregnancies (which often results from exposure to environmental 
estrogens or xenoestrogens). Aneuploidy is one of the prevalent causes for genetic 
disorders in humans and it arises from anomalies in the chromosome content of the 
gametes (sperms and ova). Any disruption in the normal meiotic events during fetal 
gametogenesis may be amplified along the way to give rise to aneuploid gametes. 
Meiotic studies in model organisms are therefore indispensable to our understanding of 
human aneuploidy. In summary, this dissertation project has focused on the critical role 
	  
	  
of steroid hormone regulation of fetal mouse oocyte development and its role on meiotic 
progression, thus contributing to our understanding of early ovarian differentiation.  
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1.1. Significance 
       A critical but poorly understood aspect of ovarian biology is the assembly of 
primordial follicles early in development. This process gives rise to the finite reservoir of 
oocytes available to a female mammal during her entire reproductive life (Kezele et al., 
2002). Defects in the process of follicular assembly or inappropriate activation during 
primordial follicle development can give rise to a series of reproductive diseases. This 
can lead to disorders like premature ovarian failure or physiological changes like 
menopause in humans (Kezele et al., 2002). The tight regulation of the size of the 
primordial follicle pool is critical for the maintenance of female fertility (Pepling, 2006). 
Thus, studies elucidating the factors responsible for primordial follicle assembly and 
activation are critical to develop potential therapeutic treatments for these conditions. The 
primordial follicle is composed of an oocyte primarily arrested at the diplotene stage of 
prophase I of meiosis and is surrounded by squamous epithelial or pre-granulosa cells. 
The primordial follicles typically assemble around the time of birth in rodents and by the 
third trimester in humans and cattle (Gondos et al., 1971; Russe, 1983). This dissertation 
primarily focuses on two main aspects of early mouse oogenesis, synthesis of steroid 
hormones by perinatal ovaries and the link between diplotene arrest and follicle 
formation. 
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1.2. Ovarian Development 
       In mammals, oogenesis initiates during early fetal development and takes months to 
years to complete (Eppig, 2004) (Figure 1.1). Precursors for germ cell populations are 
established during the embryonic period (Hirshfield, 1991). In the mouse, the germ cell 
lineage derives from a founder population of approximately 45 primordial germ cells 
(PGCs) (Lawson and Hage, 1994). The PGCs are motile and highly responsive to 
chemotaxic stimuli that enable them to migrate from their site of origin (i.e., the 
embryonic epiblast) to the genital ridge. In mouse, PGCs are first observed in the yolk 
sac around 7.5 days postcoitum (dpc) (Snow, 1983). The migratory events occur between 
9.5 dpc and 11.5 dpc (Figure 1.1).  
      During early embryonic life, the ovary develops from the indifferent gonad. The 
indifferent gonad is composed of mesenchymal cells derived from the genital ridge 
(Yoshinaga et al., 1988). PGCs enter the indifferent gonad around 10.5 dpc and are 
henceforth termed oogonia. After colonization, they rapidly proliferate to increase in 
number (generation time is around 15-16 hours in mouse) (Snow, 1983; Tam, 1981). As a 
result, the number of germ cells increases from 25,000 to 83,000 (Kezele et al., 2002; 
Snow, 1983). The somatic cells of the gonad which later give rise to the granulosa, theca, 
endothelial cells of the mature follicles also proliferate extensively like the germ cells.  
       The mitotic division of PGCs coupled with incomplete cytokinesis, produce clusters 
of oogonia known as ovarian germ cell cysts or nests (Pepling, 2006; Wylie, 1999). Germ 
cell cysts are composed of a pocket of germ cells surrounded by a layer of stromal cells. 
In certain species like cattle and pig, the stromal cells organize into histologically distinct 
4	  
	  
	  
	  
“ovigerous cords” surrounding the oogonia (Hirshfield, 1991). The origin of the stromal 
cells or cords enclosing the germ cell nests is not known (Hirshfield, 1991; Jost, 1988; 
Sawyer et al., 2002). Some evidence indicate that the cords may be derived from 
coelomic epithelium(Sawyer HR, 2002)  though most evidences support that ovigerous 
cords arise from ovarian rete (Byskov and Lintern-Moore, 1973; Hirshfield, 1991; Kezele 
et al., 2002; Wenzel, 1985). The stromal cells or the ovigerous cords later form the pre-
granulosa cells surrounding the primordial follicle (Kezele et al., 2002). The ovigerous 
cords, present in the ovaries of certain species like cattle, pig and cat divide the 
embryonic ovary into two distinct compartments separated by the basement membrane. 
The inner compartment containing the germ cells is known as epithelioid compartment 
and the outer one is called interstitial or mesenchymal compartment (Hirshfield, 1991).   
       The population of germ cells expands through mitotic divisions and undergoes one 
last round of DNA replication, before entering meiosis around 13.5 dpc. The germ cells 
are henceforth known as oocytes (Franchi, 1973; McLaren, 2000a). The two events, 
expansion of the germ cell population by mitosis and entry into meiosis are fairly 
synchronized with 19.5 % of germ cells entering meiosis and 80% proliferating at 13.5 
dpc which rapidly decreases to only 23.5 % proliferating cells at 14.5 dpc (Evans et al., 
1982).  In humans, meiotic oocytes are first observed during the second month of 
gestation even though at 5 months, 28.6% of the germ cells are still mitotically active 
(Baker, 1963). By the seventh month of gestation, the last germ cells enter meiosis 
(Peters, 1976).  
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1.3. Germline cysts 
       Germline cysts were first studied in a wide variety of  insects (e.g., Drosophila, 
beetles, bees, aphids) where female germ cells develop in clusters of interconnected cells 
that share several distinctive characteristics (Brunet and Verlhac, 2011; Bu¨ning, 1994). 
During cyst formation, there is an individual founder cell also referred to as a germline 
stem cell. The germline stem cell divides to form a daughter stem cell and a cystoblast. 
The cystoblast gives rise to the cyst. Cysts grow from the progenitor cell or cystoblast 
progressively by mitosis without undergoing any cytokinesis. The daughter cells known 
as cystocytes are normally formed in clusters of cells corresponding to 2n (n can vary 
from 1 to 8 depending on the species) (Bu¨ning, 1994). Due to incomplete cytokinesis, 
the individual cystocytes are interconnected with one another by intercellular bridges 
known as ring canals. Germ cell clusters exhibiting characteristics of cysts have been 
observed in several vertebrate ovaries which indicate that it is a conserved trait across the 
vertebrate kingdom (Gondos, 1973). Small clusters of premeiotic germ cells have been 
found in mice, rabbits, rats, hamsters and humans. A detailed examination by electron 
microscopy revealed that intercellular bridges strongly resemble ring canals that connect 
those premeiotic germ cells. The germ cells in those organisms are also found to divide 
synchronously in small groups similar to germline cysts (Franchi and Mandl, 1964; 
Gondos, 1987; Gondos et al., 1971; Gondos and Zamboni, 1969; Pepling, 2013; Ruby et 
al., 1969; Weakly, 1967; Zamboni and Gondos, 1968). 
       Drosophila oogenesis has long been a favorite system to study cyst formation. 
Drosophila has two ovaries and each ovary consists of 16 ovarioles. Each ovariole 
represents an independent egg assembly line. The anterior region of each ovariole is 
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known as the germarium which consists of 2 germline and somatic stem cells which gives 
rise to mature egg chambers (follicles) (Spradling, 1993). A typical germarium has the 
following structures: one cystoblast (cyst founder cell), three successive stages of 
forming cysts, six cysts of sixteen cells and one egg chamber at the posterior end. Egg 
chambers leave the germarium from the posterior end. The egg chamber consists of a 
sixteen cell cyst and is surrounded by follicle cells. Egg chambers move posteriorly 
within each ovariole as they are developing. Each egg chamber develops from a 16-cell 
germline cyst. Cyst formation is initiated by the asymmetric division of one of the two 
germline stem cells in the germarium to produce a cystoblast. The cystoblast compared to 
its sister stem cell exhibits a unique pattern of cell division. It undergoes four additional 
cell divisions without any cytokinesis causing the daughter cells or cystocytes to be 
interconnected with one another by intercellular bridges or ring canals. One cell from the 
16-cell germline cyst develops into an oocyte and the rest serve as nurse cells. Electron 
microscopic studies reveal a continuous flow of cytoplasmic organelles like 
mitochondria, ribosomes, maternal mRNAs as well as other nutrients through the ring 
canals from the nurse cells to the oocyte (Spradling, 1993). The characteristic “dumping” 
of cytoplasmic contents by the nurse cells occurs by increased cytoplasmic oscillations 
and streaming in the nurse cells and oocytes (Gutzeit, 1982). The nurse cells when treated 
with a drug called colchicine which inhibits microtubule polymerization exhibits 
complete loss of cytoplasmic transport into the oocyte (Gutzeit, 1986). This suggests that 
microtubules are present inside the ring canals or intercellular bridges and they facilitate 
the intercellular transport between nurse cells and oocyte.  
7	  
	  
	  
	  
       One of the striking features of ring canals is the presence of an unusual vesicle rich 
cytoplasmic organelle known as the fusome. The mitotic spindle fibers, in dividing cells 
orient their poles adjacent to the fusome. Mutants defective in fusome formation do not 
undergo cyst formation and are unable to form functional gametes (Brunet and Verlhac, 
2011). Fusomes are composed of  membrane skeletal proteins like	  α-spectrin, β-spectrin, 
and the adducin like product of the hu-li tai shao (hts) gene, motor protein dynein, and 
the protein expressed by the bag-of-marbles (bam) gene (de Cuevas et al., 1996; Deng 
and Lin, 1997; Lin et al., 1994). The fusome arises from a precursor known as 
spectrosome present in the Drosophila germline stem cells (Lin and Spradling, 1997; Lin 
et al., 1994). Mutations in α-spec and hts result in abnormally small cysts, which do not 
have 2n cells (de Cuevas et al., 1996; Deng and Lin, 1997; Lin et al., 1994; Yue and 
Spradling, 1992). α-spec and hts are essential components of fusome and their mutations 
result in a nonfunctional fusome. This highlights the fact that the fusome plays a pivotal 
role in cell divisions (Brunet and Verlhac, 2011). 
       There has been evidence that germ cell clusters connected by intercellular bridges are 
present in 17 or 18 day fetal mice ovaries (Ruby et al., 1969). It was unclear at that time 
whether the observed intercellular bridges are true “germline cysts” like those in 
Drosophila. Electron microscopic studies first revealed the presence of microtubule 
bundles in the intercellular bridges connecting germ cell clusters in mice ovaries (Vegetti 
and Alagna, 2006). Moreover, mitochondria were found in those intercellular bridges 
reinforcing the fact that intercellular transport occurs via the intercellular bridges (Vegetti 
and Alagna, 2006). Another important feature of a germline cyst is that they are 
mitotically synchronized, the daughter cells known as cystocytes are normally formed in 
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cluster of cells corresponding to 2n.  If the germ cell clusters were formed by cell 
aggregation, their numbers would have been unsynchronized. A high degree of mitotic 
synchrony was found in the germ cell clusters in 10.5 dpc-15.5 dpc ovaries when most of 
the germ cells are at premeiotic stage. Most of the clusters contained 2, 4, 8 or 16 mitotic 
cells. This indicates that the clusters are formed by rounds of synchronous divisions with 
incomplete cytokinesis (Vegetti and Alagna, 2006). To examine another important 
hallmark, fusomes of germline cysts, ovaries were labeled with anti-EMA (a marker for 
germ cells). EMA labeling images indicated the presence of a fusome-like structure  
which was associated with the poles of mitotic spindles (Vegetti and Alagna, 2006). 
However, it was not asymmetrically distributed during cell divisions like Drosophila 
fusomes.  
       Alternatively, there have been reports supporting the “aggregation theory” to 
document the formation of germ cell clusters (Gomperts et al., 1994). PGCs are often 
connected by long processes known as filopodia while they are migrating to the gonad. 
The filopodial connections are generally lost once the PGCs reach the gonads around 
11.5 dpc. Germ cells at 10.5 dpc when cultured in vitro, were found to aggregate. These 
findings led the authors to postulate that germ cell clusters arise by aggregation of germ 
cells instead of incomplete cytokinesis (Bendel-Stenzel et al., 2000; Gomperts et al., 
1994). Recent observations confirmed that all germ cell clusters are not formed by 
incomplete cytokinesis, some may be formed by aggregation too (Mork et al., 2012).  
       A defined role for murine germline cysts has not been found yet. Only one-third of 
the oocytes within each cyst survive to form primordial follicles and rest are lost by germ 
cell attrition (Pepling and Spradling, 2001). Germ cell attrition has been observed  in 
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germ cells serving as nurse cells in the Drosophila ovary (Brunet and Verlhac, 2011). 
One or more oocytes within each murine germline cyst may accumulate materials 
transported from the others that would determine them as oocytes (Vegetti and Alagna, 
2006). It has been postulated that in mammalian oogenesis, all premeiotic germ cells 
might not be oogonia, some may be nurse cells too (Gondos, 1973). The oocytes which 
undergo attrition within each murine cyst might be analogous in function to nurse cells in 
Drosophila. Those oocytes serving as nurse cells in mice might transport their cellular 
organelles like mitochondria, mRNAs, centrioles, ribosomes to the future oocytes and 
undergo attrition (Vegetti and Alagna, 2006). 
         
1.4. Germ Cell Attrition 
       Extensive loss of germ cells occur as they enter meiosis (Baker, 1972; Coucouvanis, 
1993; Ratts, 1995). Germ cell degeneration appears to occur in four waves during rodent 
oogenesis reducing the oocyte number from 75,000 on 18.5 dpc to only 27,000 at 
Postnatal Day (PND)2 (Beaumont, 1962). During the postnatal period (days 1-6), some 
oocytes migrate through the germinal epithelium and are lost by elimination into the 
peritoneal cavity (Hiura and Fujita, 1977). Germ cell attrition occurs mostly during the 
first 30 days postnatal and is seldom observed in older animals (Edwards et al., 1977). 
     The majority of the germ cell cysts in mouse break down to form primordial follicles 
within two days after birth (PND2) (Pepling and Spradling, 2001). Recent findings from 
our laboratory revealed that cyst breakdown and follicle formation can start two days 
prior to birth at 17.5 dpc particularly deeper in the ovarian tissue (medullary region) 
(Pepling et al., 2010). During the process of cyst breakdown, about two-thirds of the cells 
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within each cyst die by programmed cell death and the rest (one-third) of the oocytes 
ultimately develop into primordial follicles (Figure 1.2). Thus, programmed cell death is 
a requisite for bigger cysts to break down to smaller cysts and ultimately form primordial 
follicles. The two important events during oogenesis, cyst breakdown and oocyte death 
occur within the same temporal time frame. However, there is no evidence to address 
whether they are developmentally linked processes. There are no definite reasons yet 
known to explain the huge oocyte loss associated with germ cell cyst breakdown 
(Pepling, 2006). Another wave of apoptosis occurs during sexual maturity when cohorts 
of follicles are recruited to grow by a process called follicle activation (McGee and 
Hsueh, 2000). Some of the activated follicles eventually die by a process called follicular 
atresia while oocytes in surviving follicles undergo ovulation (Pepling, 2012). We still do 
not know the exact function and mechanism of germ cell attrition. Apoptosis or 
programmed cell death is believed to play the major role. Two major hallmarks of 
apoptosis, germ cell shrinkage and nuclear chromatin condensation were both found  in 
the mouse ovaries between 13.5 dpc and PND1 (Coucouvanis, 1993). Furthermore, dying 
oocytes from mouse ovaries aged between 15.5 dpc and PND1 had  the characteristic 
DNA laddering pattern of apoptosis (Ratts, 1995).     
       Programmed cell death of oocytes is found to be conserved throughout the animal 
kingdom. In C. elegans, 50% of the germ cells are lost by apoptosis of oocytes arrested 
during the pachytene stage of meiosis (Gumienny et al., 1999). In many invertebrate 
females, only a fraction of the cells within each cyst ultimately give rise to mature 
oocytes (Bu¨ning, 1994). In Drosophila, only one of a 16-cell cyst stage becomes the 
oocyte and the rest of the 15 cells known as cystocytes serve as nurse cells. They help in 
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the growth of the oocyte by supplying mRNAs, proteins, and organelles to the oocyte. At 
the end of oogenesis, there is rapid, bulk transport of nurse cell cytoplasm leading to the 
growth of the oocyte and the nurse cells then die by apoptosis (Spradling, 1993).  
       Apoptosis occurs in other systems like the nervous and immune systems during the 
course of development. The principle for cell death in the ovary may be due to similar 
functions like those systems. During both early neuro- and lymphogenesis, cells are 
overproduced. They are subjected to at least two different waves of apoptosis both in 
utero and during the postnatal period (Elmore, 2007). Various factors like neurotrophic 
factors may restrict the number of developing neurons during the proliferative period and 
post-mitotically. This process helps to determine the number of neurons  and also 
appropriate, functional synaptic connections to form between neurons (Yuan and 
Yankner, 2000). In the lymphatic system, young lymphocytes are overproduced. The 
initial cell numbers are reduced due to limited cytokine availability. Further apoptosis 
may occur on the reduced cell population to generate lymphocytes with functional 
antigen receptors. This process ensures that the lymphocytes are equipped with the 
appropriate level of responsiveness required for the efficient functioning of the immune 
system (Opferman, 2008). The underlying theme is that cells in the above two systems 
undergo apoptosis to regulate their population as their modules of functionality are 
assembled. This process ensures that the two systems function with highest efficiency. In 
the ovary, analogous to nervous and immune systems, oocyte numbers decrease as the 
functional units of the ovary, the follicles get assembled.  
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1.5. Meiotic progression and folliculogenesis 
       In mouse, the majority of primordial follicles are formed after birth. Primordial 
follicles consist of small oocytes (~ 20 µm in diameter) enclosed in a single layer of 
squamous or flat somatic cells known as the pre-granulosa cells. The pre-granulosa cells 
do not express follicle stimulating hormone (FSH) receptor and do not respond to 
hormonal stimulation (Oktay et al., 1997). The primordial follicles remain in the resting 
stage, until they either degenerate or enter the growth phase. By PND7, most of the 
oocytes are enclosed in primordial follicles with very few cysts remaining. During the 
first week of development, an initial synchronous wave of follicle recruitment takes 
place. Once recruited into the pool of primary follicles, oocytes grow in size and the 
surrounding pre-granulosa cells become cuboidal and proliferative.   In female mammals, 
the recruitment of primordial follicles continues throughout the reproductive lifespan. 
The process of transition of resting stage-oocytes to subsequent growth and 
differentiation is known as folliculogenesis (Figure 1.3). Primary follicles increase in 
size both by the proliferative action of granulosa cells and an increase in size of the 
oocyte. When the follicles reach the secondary (or preantral) stage, they are characterized 
by two or more layers of granulosa cells surrounding the oocytes. Primary and preantral 
follicles are responsive to gonadotropins and therefore optimal development of preantral 
follicles require gonadotropin stimulation (Cortvrindt et al., 1997; Fortune and Eppig, 
1979). A fluid-filled antrum forms between the layers of somatic cells as granulosa cells 
continue to divide and the oocyte enlarges to form the antral /Graafian follicle. In the 
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mouse, the first cohort of growing follicles reaches this stage between PND 14 and 24. 
The granulosa cells are divided into two separate compartments by the growing antrum. 
Those closest to the oocyte are called cumulus cells and those lining the follicle wall are 
the mural granulosa cells. The first wave of follicles formed before puberty eventually 
degenerate in absence of appropriate gonadotropin surge. 
       An oocyte within the primary or preantral follicle is arrested at diplotene stage of 
prophase I of meiosis and hence meiotically incompetent. It still does not have the 
regulatory machinery to drive meiotic progression. It cannot mature spontaneously if 
removed from the follicle and placed in supportive medium. During the transition from 
preantral to antral stage, a critical developmental change takes place in the oocyte. The 
oocyte reaches its full size (~ 75 µm diameter in the mouse). This is accompanied by an 
increase in both the rate of protein synthesis and total cellular protein content. Once the 
oocyte reaches the optimal size, it acquires the capacity to undergo germinal vesicle 
breakdown (GVBD) and complete the first meiotic division (Sorensen and Wassarman, 
1976). Henceforth, it attains the capacity to support fetal development (Kono et al., 
1996). An oocyte removed from the antral follicle and placed in appropriate medium will 
spontaneously resume meiosis. Luteinizing hormone (LH) receptors develop on mural 
granulosa cells as the follicle enlarges. The granulosa cells, in response to the midcycle 
surge of LH undergo changes in gene expression that indirectly stimulate oocyte meiotic 
maturation (Hernandez-Gonzalez et al., 2006). In most mammals, before ovulation 
oocytes resume meiosis and progress to metaphase II. In response to a LH surge, the 
large antral/preovulatory follicle ruptures resulting in ovulation of a metaphase II-arrested 
oocyte which is competent to undergo fertilization. Lastly, the mural granulosa cells 
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remaining in the ovary undergo a differentiation event known as luteinization. These cells 
together with the adjacent theca cells form the corpus luteum, essential for the 
maintenance of pregnancy (Figure 1.4). 
 
1.6. Diplotene arrest and follicle formation 
       The overall goal of folliculogenesis is to produce eggs competent to resume meiosis 
and undergo complete nuclear maturation, to produce haploid gametes capable of 
supporting embryonic development (Brunet and Verlhac, 2011). Meiosis is a unique 
cellular process consisting of one round of DNA replication and two rounds of cell 
division, producing the haploid sperm or egg. It consists of two successive cell divisions. 
Meiosis I separates homologous chromosomes, producing two haploid cells with n 
chromosomes. Meiosis I is therefore termed as reductional division.  In Meiosis II, 
equational division by mitosis occurs whereby the sister chromatids are finally split, 
generating a total of 4 haploid cells (two from each daughter cell from the first division). 
Prophase of the first meiotic division (MI) is the longest phase and has five different 
stages (leptotene, zygotene, pachytene, diplotene, diakinesis) (Freeman, 2005) (Figure 
1.5). During meiotic prophase I, homologous chromosomes by a process known as 
meiotic recombination undergo reciprocal DNA exchange. The paternal and maternal 
allelic combinations are thus shuffled along the chromosome, generating genetic 
diversity. After recombination, the homologous chromosomes move to opposite poles of 
the spindle and segregate. Leptotene is the first stage of meiotic prophase I during which 
progressive condensation and coiling of chromosome fibers takes place.  Zygotene occurs 
next during which pairing known as synapsis of homologous chromosomes takes place. 
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The pairing is highly specific and exact. The homologous chromosomes are of identical 
length and pairing ensures that they are correctly positioned around their centromeres. 
The paired chromosomes are known as bivalents. Pachytene is the next stage to follow. 
Nonsister chromatids of homologous chromosomes exchange segments over regions of 
homology by a process known as crossing over. Sex chromosomes (X and Y) are of 
unequal length and undergo crossing over around a small region of homology. 
A protein structure known as the synaptonemal complex (SC) forms between the 
homologous chromosomes which serve as a scaffold to facilitate interacting chromatids 
to undergo meiotic crossover activities. The points along the chromosomes where 
crossing over has occurred are known as chiasmata. It represents the actual break of the 
phosphodiester bond during crossing over. Diplotene occurs next where the homologous 
chromosomes separate from one another due to the degradation of the synaptonemal 
complex. They are held tightly mainly at the points of crossing over or chaismata till they 
are severed in anaphase I. During mammalian oogenesis, all developing oocytes develop 
to the diplotene stage and remain suspended until ovulation (Rosenbusch, 2006). This 
resting phase of the oocytes is also known as the dictyate stage. The final stage of meiotic 
prophase I is diakinesis. More condensation of the chromosomes occurs, the tetrads 
become more prominent with the chaismata clearly visible. The nuclear membrane and 
nucleolus disintegrate along with the formation of meiotic spindle in preparation of 
metaphase I. In the second meiotic division (MII), sister chromatids segregate, similar to 
a mitotic division, giving rise to haploid daughter cell(s).  
       Diplotene arrest and follicle formation occur during the same temporal period. Stra8 
is essential for meiotic entry of oocytes and germ cells in Stra8-  mice do not enter 
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meiosis (Baltus et al., 2006).  However, follicles are observed in Stra8- mutant mice 
ovaries at puberty with the oocyte nuclei at mitosis (Dokshin et al., 2013). In rats, 
inhibition of synaptonemal complex protein (SYCP)1 resulted in premature arrival of 
oocytes at the diplotene stage and precocious assembly of primordial follicles suggesting 
a link between cell cycle stage and primordial follicle formation (Paredes et al., 2005).	  
Sycp1 mice mutants are sterile and females lack oocytes though follicle formation was 
not examined (de Vries et al., 2005).	  SYCP3 mutants have defective chromosome 
segregation. Their oocytes appear to develop normally though they are subfertile (Yuan 
et al., 2002).	  In cattle, the primordial follicles are at the pre-diplotene stage. It has been 
shown that activation of the primordial follicles to form primary follicles is related to 
their ability to attain diplotene stage. Furthermore,	  estrogen can block follicle activation 
by inhibiting meiotic progression (Yang and Fortune, 2008). In mouse, bisphenol A 
(BPA) treatment of mouse embryos caused defects in meiosis. Estrogen receptor (ER) β 
mutants had meiotic defects like the BPA-treated animals, suggesting that BPA acts as an 
ERβ antagonist (Susiarjo et al., 2007). 
 
1.7. Endocrine Disruptors 
       The post-World War II era saw a massive explosion in industrial growth. Thousands 
of man-made compounds were introduced into the environment as industrial waste. In  
the US, more than  80,000 chemicals are found in products ranging from toys and food 
packaging to detergents and pesticides.	  Recently, there has been an increasing concern 
among the scientific community, general public and  the policy makers regarding the 
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potential reproductive hazards of a range of  environmental chemicals known as 
‘endocrine disruptors.’  
        An endocrine disruptor is defined as an exogenous agent that can interfere with the 
synthesis, secretion, transport, metabolism, binding, action, or elimination of natural 
blood-borne hormones in the body that are responsible for reproduction, and 
developmental processes (Kavlock and Ankley, 1996). A developing embryo or a fetus is 
more sensitive than adults because of underdeveloped DNA repair mechanisms and 
incomplete functions of detoxifying enzymes (Trubo, 2005). Thus, endocrine disruptors 
at this stage can produce disruptions in reproductive development at a concentration 
much lower than which can produce effects in adults. Some of the widely used chemicals 
used on a daily basis and act as endocrine disruptors are phthalates (widely used 
plasticizers), polychlorinated biphenyls (PCB) (used in transformers and electric 
equipment), and the insecticide DDT. The best-documented case of estrogen exposure in 
humans has come from the use of diethylstilbestrol (DES) widely prescribed by the 
physicians in the United States between 1940s and 1970s to prevent miscarriages (Smith, 
1949). DES was not only ineffective in preventing miscarriages but had long-term and 
multigenerational effects in causing reproductive disorders. Ultimately, it was banned in 
1971 by the U.S. Food and Drug Administration (FDA).  
       Many studies suggest the potential relationship between human exposure to 
environmental factors and increased nondisjunction of chromosomes in germ cells. But 
the risks still remain unclear and limited. More studies are thus necessary to establish a 
definitive impact of endocrine disruptors on human reproduction. One approach is to 
utilize the mouse as a mammalian model to study such relationship.  
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1.8. Estrogen (E2) and Progesterone (P4) receptors 
       Both E2 and P4 are endogenous hormones with important physiological roles 
targeting the reproductive tissues, brain, bone, and cardiovascular system. In the classical 
steroid signaling pathway, E2 action is mediated through binding to nuclear receptors 
(ERs) that regulate transcription of estrogen responsive genes (Figure 1.6). In mammals, 
there are two main estrogen receptors (ER)s - ERα and ERβ, containing a conserved 
DNA-binding domain (Pettersson and Gustafsson, 2001).	  The ligand, E2 on binding with 
the receptor induces its conformational changes. This leads to ER dimerization and the 
receptor dimer then recruits a multi-component coactivator or corepressor complex. The 
coactivator or corepressor complexes then interact with basal transcription factors and 
induce either stimulation or inhibition of target genes containing the estrogen response 
element (ERE).	  Apart from the ‘classical’ steroid hormone signaling, estrogen can signal 
through other mechanisms like tethered, ligand-independent, and membrane signaling  
(Heldring et al., 2007).	  In tethered signaling, ER does not directly bind to the DNA unlike 
classical signaling. E2 activates ERs, which in turn, interact with other transcription 
factors and bind to target DNA sequences (Kushner et al., 2000; Saville et al., 2000).	  For 
ligand-independent signaling, ERs are not activated by ligand binding. They are 
phosphorylated by activation of other signaling pathways and then bind to EREs to 
modulate target gene transcription (Kato et al., 1995).	  E2 can signal through the 
membrane via two ways.	  First,	  nuclear ERs can directly translocate to act at the plasma 
membrane (Pedram et al., 2006). Secondly, E2 can also signal through membrane bound 
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receptors (mERs) including a G protein-coupled membrane receptor called GPR30 
(Revankar et al., 2005).	  Evidence for other G protein-coupled receptors for estrogen 
exists but they have not been well characterized (Hasbi et al., 2005). 
       ERα mutants are sterile with ovaries lacking corpora lutea and containing 
hemorrhagic follicles (Lubahn et al., 1993). ERβ mutant adult females have reduced 
fertility with fewer litters and fewer pups per litter. Their ovaries have many dying 
oocytes in atretic follicles and fewer corpora lutea (Krege et al., 1998). This observation 
suggests that in absence of ERβ, ERα may compensate for the lack of ERβ and thus ERβ 
mutant females are not completely infertile. Mice lacking both ERα and ERβ receptors 
(αβERKO) are infertile. They have normal early folliclular growth and development but 
the growth is arrested prior to the antral stage (Couse and Korach, 1999; Dupont et al., 
2000). The complete sterility of ERα females may be mainly due to lack of estrogen-
mediated negative feedback on pituitary LH secretion (Couse et al., 2003; Schomberg et 
al., 1999). ERβ mutant adult females show aberrant expression of markers of granulosa 
cell differentiation such as the LH receptor and aromatase. Their granulosa cells exhibit a 
reduced response to FSH, and are not able to respond appropriately to LH-induced 
cumulus expansion, follicle rupture, and ovulation (Couse et al., 2005). Thus, the role of 
ERβ as the primary regulator in follicle development is more defined (Woodruff and 
Mayo, 2005). 
       P4 signals through the nuclear progesterone receptor (PR) that has two isoforms, PR-
A and PR-B. They are transcribed from a single gene using two different promoters 
(Conneely et al., 1989; Kastner et al., 1990). Both PR isoforms are found in the thecal 
and granulosa cells of the adult ovary (Gava et al., 2004).	  PR-A-specific knockouts have 
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defects in ovarian and uterine function and PR-B-specific knockouts have defects in 
mammary gland function (Mulac-Jericevic et al., 2003; Mulac-Jericevic et al., 2000).	  The 
PR knockout females lacking both PR-A and PR-B receptors are sterile (Lydon et al., 
1995).	  Progesterone also signals through membrane receptors by at least three 
mechanisms (Peluso, 2006).	  First, the nuclear isoforms, PR-A and PR-B can be 
translocated to the nuclear membrane.	  The second type is a seven-transmembrane 
spanning family of PRs called progestin and adipoQ receptors (PAQR) present with 
members in three groups- α, β, and γ.	  The third types identified are two single membrane-
spanning proteins called progesterone receptor membrane component (PGRMC) 1 and 
PGRMC2 can act as PRs in complex with other proteins. Their presence has been 
confirmed in the adult mouse ovary and their expression in the neonatal mouse ovary is 
yet to be examined (Cai and Stocco, 2005; Peluso, 2006). In neonatal rat ovaries, both	  
PGRMC1 and PGRMC2 are detected by microarray and  qPCR	  analysis (Nilsson et al., 
2006). 
    
1.9. Influence of hormones on cyst breakdown and primordial follicle formation 
       High levels of steroid hormones (both E2 and P4) maintain oocytes in cysts and the 
drop in their levels trigger cyst breakdown and formation of follicles (Chen et al., 2007). 
When	  female neonatal mice are treated with E2 (Iguchi et al., 1986), with xeno estrogens 
DES (Iguchi et al., 1990) or BPA (Suzuki et al., 2002) or with the phytoestrogen 
genistein (Jefferson et al., 2002), they have multiple oocyte follicles (MOF)s in their 
ovaries at the adult stage. MOFs are likely oocyte cysts that did not separate and became 
enclosed in follicles (Gougeon, 1981; Iguchi and Takasugi, 1986; Iguchi et al., 1986) 
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(Figure 1.7). To examine whether receptors for steroid hormones are present in the 
neonatal ovaries, immunocytochemistry was performed on the neonatal ovaries. ERα was 
found to be expressed in pregranulosa cells and ERβ in some oocyte nuclei during cyst 
breakdown (Chen et al., 2009).	  For further investigation, neonatal ovaries were treated 
with ERα or ERβ agonists and were seen to have reduced cyst breakdown compared to 
controls (Chen et al., 2009). This suggests that E2 can signal through either receptor to 
regulate cyst breakdown. ER knockouts though do not exhibit any defects in neonatal 
oocyte development (Tang & Pepling, unpublished observations).	  These results indicate 
that E2 signals via another receptor to maintain oocytes in cysts. E2 conjugated with BSA 
cannot enter the cell because of its size but shows the same effect as free E2 to block cyst 
breakdown. This supports the idea that a membrane receptor might be potentially 
involved in cyst breakdown (Chen et al., 2009). Gpr30 knockout mice are fertile and have 
no reproductive defects making it an unlikely candidate function as the membrane 
receptor in neonatal ovaries (Otto et al., 2009).  
     Unlike mice, E2 seems to have a positive effect on follicle formation in some species. 
There are species differences in E2 signaling (Pepling, 2012). There is no evidence to 
indicate why E2 promotes follicle formation in some species and inhibits follicle 
formation in others.  E2 has been shown to promote follicle assembly in hamster (Wang et 
al., 2008; Wang and Roy, 2007).	  In baboons, cyst breakdown and follicle assembly are 
disrupted if E2 production is inhibited (Zachos et al., 2002). 
       The source of E2 and P4 maintaining oocytes in cysts during the fetal period in mice 
is unknown. In humans, maternal E2 levels are high during primordial follicle formation. 
Whereas in cattle, maternal E2 levels are low before follicles  form during gestation 
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suggesting that maternal circulating E2 is not the source in these species (Senger, 2003). 
It has already been shown that fetal bovine ovaries can synthesize E2 and P4 and the 
levels subside when primordial follicles begin to form (Nilsson and Skinner, 2009; Yang 
and Fortune, 2008).	  	  
       Neonatal treatment with P4 can also give rise to MOFs in adult females (Iguchi et al., 
1986). Neonatal treatment of mice and rat ovaries with P4 reduces cyst breakdown and 
primordial follicle formation (Chen et al., 2007; Kezele and Skinner, 2003).	  P4 can be 
converted to E2 and its effect could be exerted either directly or via conversion to E2.	  To 
investigate that possibility,	  a non-metabolizable analog of P4 (promegestone) was also 
found to block follicle formation in rat and mice ovaries (Chen et al., 2007; Nilsson et al., 
2006).	  Two studies confirmed that fetal bovine ovaries are capable of synthesizing P4 to 
regulate their own folliculogenesis (Nilsson and Skinner, 2009; Yang and Fortune, 2008). 
       Testosterone (T) when given as a neonatal treatment can give rise to MOFs in the 
adult stage (Iguchi et al., 1986).	  The direct effect of T on cyst breakdown has not been 
yet investigated; it could due to its conversion to E2. One study indicated that inhibiting 
E2 synthesis from T can reduce the incidence of MOFs (Iguchi et al., 1988).	  T signals 
through the androgen receptor (AR) belonging to the nuclear steroid hormone receptor 
family (Roy et al., 1999) and can also signal through receptors at the membrane (Heinlein 
and Chang, 2002). 
 
1.10. Aromatase and 3-beta-hydroxysteroid dehydrogenase  
       The aromatase enzyme is localized in the endoplasmic reticulum of the cells that 
synthesize E2 (Sebastian and Bulun, 2001).	  Aromatase P450 (CYP19) is an enzyme 
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which catalyzes the conversion of androgens into estrogens (Figure 1.8).	  In humans, 
aromatase is expressed in a number of cells, such as the ovarian granulosa cells, the 
placental syncytiotrophoblast, the testicular Leydig cells, brain and skin fibroblasts 
(Simpson et al., 1994). The tissue-specific expression of this gene is controlled using 
alternative splicing by means of tissue-specific promoters. The protein translated from the 
message is the same in all tissues (Simpson et al., 1997).  
       Aromatase is mostly restricted to the gonads and brain in rodents (Stocco, 2008). In 
female adults, aromatase is mostly present in the follicle and the corpus luteum of the 
ovaries. The expression of this gene is controlled in a cell-specific and temporal manner. 
This expression pattern ensures that E2 synthesis occurs only in mural granulosa cells of 
healthy large antral follicles and luteal cells (Stocco, 2008). In several species like 
humans, rabbit and cattle, ovaries acquire the enzymatic capacity to synthesize E2 during 
embryonic life (George and Ojeda, 1987; Vigier et al., 1989). Fetal ovaries in humans 
and rabbits have been demonstrated to exhibit aromatase activity by their ability to 
convert radiolabeled androgen to estrone and estradiol (George and Wilson, 1978; 
Milewich et al., 1977; Vigier et al., 1989). ERα and ERβ knockout mice show no defects 
on cyst breakdown and early follicle development and thus the role of E2 during fetal 
ovarian development is still unclear (Couse et al., 1999).	  LH levels are found to be 
elevated in ERα and ERβ knockout mice	  which cause premature maturation of the ovary 
and development of advanced stage follicles in prepubertal females.	  This indicates that 
the main function of E2 in pre-pubertal females is to maintain normal levels of 
gonadotropins via its regulatory negative feed-back inhibition on the pituitary gland 
(Couse et al., 1999). 
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       The earliest indication of aromatase activity and presence of aromatase mRNA are 
found at PND5 and PND8 in the granulosa cell layer of growing follicles (George and 
Ojeda, 1987; Guigon et al., 2003; Mendelson and Kamat, 2007).	  Aromatase expression 
progressively increases in preantral and antral follicles of prepubertal ovaries. Around 
PND21, it becomes mostly restricted to healthy large antral follicles (Guigon et al., 2003; 
Stocco, 2008).	  In a mature follicle such as a pre-antral follicle which possess both 
granulosa and thecal cells, LH acts on the thecal cells to produce androgen precursors and 
FSH acts on the granulosa cells to synthesize estradiol from the androgen precursors	  on 
gonadotrophin surge. However, follicles in the neonatal ovaries do not possess all the 
components of the ‘two cell (thecal/granulosa cells), two gonadotropins (LH/FSH)’ 
model and thus E2 production during the neonatal stage remains mostly elusive  (Stocco, 
2008). 
	  	  	      Mice lacking a functional aromatase enzyme (ArKO) can be generated by targeted 
disruption of the cyp19 gene (Fisher et al., 1998). Female ArKO mice at 9 weeks of age 
have underdeveloped external genitalia and uteri. The ovaries of ArKO females have 
follicles of all types (primordial, primary, secondary, and antral) but do not undergo 
ovulation. ArKO ovaries have more primary follicles compared to wild-type at 21–23 
weeks and to heterozygous ovaries both at 10–12 weeks and 21-23 weeks. There were 
significantly fewer secondary follicles in the ArKO ovaries around 10-12 weeks and by 1 
year of age, no secondary or antral follicles were observed in the ArKO ovaries. The 
ovaries do not have any corpora lutea (Britt et al., 2000; Britt et al., 2004). This 
observation suggests that estrogen is not an absolute requirement for the growth of 
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primordial follicles but is required for the development of antral follicles and subsequent 
steps in folliculogenesis which gives rise to ovulation (Britt et al., 2000).   
       When the ovarian follicles are not ovulated, they undergo atretic degeneration by 
apoptosis. This leads to the depletion of ovarian follicles at a relatively early stage of life 
in ArKO females compared to wild-type females (Toda et al., 2001). The presence of 
haemorrhagic cysts on the surface of ovaries is a very characteristic feature of aged 
ArKO females. It is speculated that the absence of estrogens (or excess of androgens) in 
ArKO females might lead to the invasion of macrophages into the follicular antrum. The 
macrophages then phagocytose and produce an empty space in the follicle, into which 
blood flows and accumulates, which gives rise to the haemorrhagic cystic follicles (Toda 
et al., 2001). ArKO males of the same age have relatively normal internal anatomy but 
have enlarged male accessory glands. Their testes look normal and they are capable of 
breeding and producing litters of average size. They have highly elevated serum levels of 
testosterone, follicle stimulating hormone and luteinizing hormone (Toda et al., 2001). 
       The enzyme 3beta-hydroxysteroid dehydrogenase (3βHSD) is present both in 
microsomes and mitochondria of mouse ovaries (Figure 1.8). Six different isoforms of 
3βHSD are present in mice (Abbaszade et al., 1997). During the follicular phase of the 
estrous cycle, the 3βHSD activity is predominant in the microsomes and on LH 
stimulation during the luteal phase it increases in the mitochondria. It could be due to the 
fact that 3βHSD is preferentially inserted into the mitochondrial membrane after LH 
stimulation (Chapman et al., 2005). 3βHSD uses NAD+ as cofactor for converting 
pregnenolone and dehydroepiandosterone (DHEA) to progesterone and androstenedione 
respectively (Chapman et al., 2005). 3βHSD I is expressed in the gonads and adrenal 
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glands of adult mouse and synthesizes adrenal and gonadal steroid hormones. 3βHSD II 
and III are expressed in the liver and kidney. 3βHSD IV is expressed exclusively in the 
kidney and is the major isoform expressed in the kidney of both sexes (Payne et al., 
1997). During diestrus (luteal phase), the specific activity of mitochondrial 3βHSD is 80 
% higher than that of microsomal 3βHSD (Chapman et al., 1992).	  During the other three 
stages of estrus, microsomal 3βHSD has the highest specific activity (Chapman et al., 
1992).	  The rate-limiting step in steroidogenesis is considered to be cholesterol side-chain 
cleavage enzyme P450scc (Miller, 1995).	  It is found that 3βHSD and P450scc have a strong 
binding affinity for each other and are simultaneously synthesized (Chapman et al., 
2005). 3β-HSD and P450scc, bound together as a complex has an added advantage in 
functioning together as a unit. They can together control the rate-limiting step, or steps, in 
conversion of cholesterol to progesterone (Cherradi et al., 1995).	  The coupling of 3βHSD 
and P450scc as an enzyme complex has further three advantages- first ,cholesterol can be 
converted to progesterone in a single step without any shuttling of steroid intermediates 
from one organelle to another.  Second, the rate of synthesis of progesterone is 
considerably increased if the reactions for both enzymes are coupled together.  Finally, 
the end-product inhibition of P450scc by pregnenolone is eliminated because 
pregnenolone can be almost immediately converted to progesterone (Chapman et al., 
2005).	  	  Thus, the synthesis of progesterone during the luteal phase involves one cell type 
and two enzymes in contrast to	  the follicular phase where steroid precursors are shuttled 
from one cell type to another and one organelle to another organelle (Chapman et al., 
2005).  
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1.11. Figures 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Migration and development of Primordial Germ Cells (PGCs) in mice.  
The PGC precursors are derived from epiblast. They are first detected during gastrulation 
at the base of the allantois around 7.5 dpc (~75 cells). They expand in number by mitosis 
and migrate through the hindgut and dorsal mesentery ultimately reaching the genital 
ridges around 10.5 dpc (~25,000 cells/each gonad primordium). Sexual differentiation 
occurs at 12.5 dpc. The oocytes undergo growth and maturation to form follicles. At 
puberty, adult females begin to release mature eggs (ova) for fertilization. 
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Figure 1.2. Cyst breakdown and germ cell attrition. Within each cyst, surviving 
oocytes are represented by the yellow color; dying oocytes are represented in green. 
Along with cyst breakdown, two-thirds of the oocytes within each cyst dies and one-third 
survives to form primordial follicles. The primordial follicles are the finite reservoir of 
germ cells available to the female mammal during her entire reproductive life span. 
Modified from: Jefferson et al., 2006 
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Figure 1.3. Stages of follicle development.  Representative confocal sections of germ 
cell cysts and ovarian follicles. Nuclei of oocytes and granulosa (somatic) cells are 
labeled with a nuclear marker, propidium iodide. A) A germ cell cyst showing several 
oocyte nuclei sharing the same cytoplasm. B) A primordial follicle containing an oocyte 
(arrowhead) surrounded by flattened granulosa cells (arrow). C) A primary follicle 
containing an oocyte (arrowhead) surrounded by cuboidal granulosa cells (arrow).  D) A 
secondary follicle containing an oocyte surrounded by several layers of cuboidal 
granulosa cells (arrow) and a layer of theca cells (double arrows) Scale bars= 
10µm.(Pepling, 2013) 
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Figure 1.4. Structure of an adult mammalian ovary. Stages of follicle development: 
primordial follicle (oocyte surrounded by a flattened layer of granulosa cells)              
primary follicle (oocyte surrounded by a cuboidal layer of granulosa cells)                
secondary follicle (oocyte surrounded by several layers of granulosa cells)                           
pre-antral  follicle (presence of a fluid filled cavity called antrum adjacent to the oocyte)         
Antral  follicle       (contains the pre-ovulatory ova which is at Meiosis I arrest)            
ovulation (mature ova released)         Corpus luteum (temporary endocrine structure 
formed in the ovary after ovulation from the follicular thecal and granulosa cells and 
secretes progesterone)          the follicular thecal and granulosa cells and secretes 
progesterone)    (Niswender, 2002; Vegetti and Alagna, 2006) 
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Figure 1.5. Early timeline of fetal mouse oogenesis.  PGCs migrate to the gonad at 10.5 
dpc. They divide by mitosis without undergoing cytokinesis to form cysts. They are 
termed as oogonia. They start entering meiotic prophase I from 13.5 dpc onwards. 
Leptotene, zygotene and pachytene begin approximately from 13.5 dpc, 14.5 dpc and 
16.5 dpc onwards. Oocytes start entering diplotene from 17.5 dpc and it may take five 
days after birth for all oocytes to enter diplotene. Cyst breakdown may start as early as 
16.5 dpc and is associated with huge germ cell loss. (Adapted from Pepling, 2006.) 
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Figure 1.6. Estrogen (E2) can signal through several different receptors. Membrane-
bound G-protein coupled receptor (GPR30), a putative membrane receptor (not yet 
characterized) and cytosolic ERα or ERβ (which are transcription factors). In the classical 
steroid signaling pathway, ligand (E2) binds to cytosolic ERα or ERβ which dimerizes on 
ligand binding and enters the nucleus. On entering the nucleus, it can bind to the DNA 
and with the help of co-activators can initiate transcription of genes having estrogen 
responsive elements (EREs).  
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Fig 1.7.  Formation of Multiple Oocyte Follicles (MOF).   A) A normal secondary 
follicle with an oocyte surrounded by several layers of granulosa cells B) Three oocyte 
nuclei surrounded by the same layers of granulosa cells forming a MOF. Oocytes are 
labeled with an oocyte marker VASA (green) and propidium iodide (red) is used to label 
nuclei. Scale bar=20µm (Pepling, 2006). 
 
 
 
 
	  
	   	   
A B 
34	  
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. Steroid Synthesis Pathway.  Cholesterol is shuttled across the mitochondrial 
membrane by steroidogenic acute regulatory protein (StAR), the rate-limiting step for 
steroid synthesis.  On entering the mitochondria, cholesterol is acted by side chain 
cleavage P450 enzyme (P-450scc) to form pregnenolone. 3βHSD acts on pregnenolone to 
synthesize progesterone. 17-hydroxylase/17-20 lyase acts on the intermediate steps to 
synthesize androstenodione (precursor for estradiol). Cytochrome P-450 aromatase then 
acts on androstenedione to synthesize estradiol. 
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1.12. Objectives 
      The overall goal of the dissertation project was to elucidate the source of steroid 
hormone signaling and its role in meiotic progression during murine fetal oocyte 
development. The first aim of this dissertation study was to identify the sources of the 
steroid hormones (maternal circulation or perinatal ovaries) which regulate fetal 
oogenesis. To investigate that, the goal was to identify the presence of the cardinal 
steroidogenic enzymes required for E2 and P4 synthesis, aromatase and 3βHSD 
respectively. Finally, we sought to determine the role of E2 and P4 synthesis during the 
perinatal period by inhibiting the enzymes- aromatase and 3βHSD by letrozole and 
trilostane respectively in organ culture treatment of perinatal ovaries. 
     We next sought to examine as the second objective of the dissertation, the relation 
between two temporal events during mice oogenesis, attainment of the diplotene stage by 
the oocytes and primordial follicle formation. A thorough quantitative analysis was 
performed to characterize and classify ovaries at different ages by nuclear morphological 
observations of diplotene versus pre-diplotene nuclei by examining H&E stained serial 
sections. We next sought to understand the role of steroid hormone signaling in meiotic 
progression of oocytes. This was carried out by organ culture treatments of perinatal 
ovaries with 10-6 M E2, 10-6 M P4 and 10-6 M E2 + 10-6 M P4.	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Chapter 2 
Source of steroid hormone signaling regulating 
fetal mouse oocyte development 
 
 
 
 
 
 
 
 
 
A part of this chapter has been accepted with revision as “Source of steroid hormone 
signaling regulating fetal mouse oocyte development” authored by Sudipta Dutta, Connie 
J Mark-Kappeler, Patricia B Hoyer and Melissa E. Pepling in Biology of Reproduction, 
April, 2014. 
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2.1. ABSTRACT 
       Primordial follicle assembly is essential for reproductive success in mammalian 
females. Oocytes develop in clusters called germ cell cysts. Beginning in late fetal 
development, cysts break down into individual oocytes that are surrounded by 
pregranulosa cells to form primordial follicles. Exposure to estradiol, progesterone or 
estrogen mimicking chemicals delays cyst breakdown and follicle formation. One model 
for cyst breakdown regulation is that steroid hormones in the maternal circulation keep 
cells in cysts during fetal development but late in pregnancy hormone levels drop 
triggering cyst breakdown. However, here we found that while maternal circulating levels 
of progesterone drop during late fetal development, maternal estradiol levels remain high. 
We hypothesized that fetal ovaries were the source of hormones and late in fetal 
development their production stops. To test this, mRNA and protein levels of 
steroidogenic enzymes required for the final step of estradiol and progesterone synthesis 
were measured. We found aromatase and 3-beta-hydroxysteroid dehydrogenase mRNA 
levels drop prior to cyst breakdown and corresponding proteins were also present. To 
determine the levels of estradiol and progesterone present, the steroid content of fetal and 
neonatal ovaries was analyzed using radioimmunoassay. Both hormones were detected in 
fetal ovaries prior to cyst breakdown. To determine the role of steroid hormones in 
oocyte development we examined effects of blocking steroid hormone production in 
organ culture and found that oocyte number was reduced. These results support our 
model that steroid hormone signaling is important for fetal oocyte development and 
contribute to the understanding of ovarian differentiation. 
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2.2. INTRODUCTION 
       Mammalian females are born with a pool of primordial follicles that represents the 
total population of germ cells available during their entire reproductive life and thus 
establishment of this primordial follicle pool is essential for fertility (Pepling, 2006). 
Oocytes start out as primordial germ cells and migrate from extra embryonic tissue to the 
genital ridge. Subsequently, they increase by mitotic division as they colonize the ovary 
between 10 days post coitum (dpc) and 12.5 dpc in the mouse (McLaren and Monk, 
1981). After arriving at the ovary, the germ cells classified as oogonia, undergo 
incomplete cytokinesis and develop in clusters of interconnected cells called germ cell 
cysts until the initiation of primordial follicle formation (Pepling and Spradling, 2001). 
At approximately 13.5 dpc, oogonia begin to enter meiosis and are henceforth classified 
as oocytes (McLaren, 2000a). They progress through the stages of prophase I of meiosis 
and then begin to arrest at the diplotene stage starting at 17.5 dpc though some oocytes 
may take up to five days after birth to reach this stage(Borum, 1961). Cysts break apart 
and most of the oocytes undergo apoptosis with only one third surviving to become 
surrounded by pregranulosa cells to form primordial follicles (Pepling and Spradling, 
2001). While a few follicles are observed as early as 17.5 dpc, most of the follicles are 
formed within the first 3 days after birth (Pepling et al., 2010). The basic mechanisms 
regulating cyst breakdown, germ cell numbers and formation of primordial follicles as 
well as how these normal processes are interrupted in reproductive disorders are still 
poorly understood. 
39	  
	  
	  
	  
       The role of sex steroids during the formation of primordial follicles has recently been 
explored in various mammals. A study in rats showed that neonatal exposure to 
progesterone (P4) but not estradiol (E2) inhibited cyst breakdown and follicle formation 
(Kezele and Skinner, 2003). However, in mice both hormones blocked cyst breakdown 
(Chen et al., 2007). To test the idea that maternal hormones might be involved in 
maintaining oocytes in cysts before birth, 16.5 dpc mouse ovaries were grown in organ 
culture media for 3 days which is equivalent to the day of birth at 19.5 dpc. In the 
absence of maternal hormones increased cyst breakdown and follicle formation was 
observed compared to PND1 ovaries in vivo (Chen et al., 2007). These observations 
helped to postulate the model that birth removes the developing mice from high levels of 
maternal circulating steroid hormones, and this in turn facilitates cyst breakdown and 
follicle formation during the early neonatal period (Chen et al., 2007).  
       Studies from other species suggest that maternal circulating hormone levels may not 
be the source of hormones regulating cyst breakdown. In humans and cattle, follicle 
formation starts during gestation, earlier than in mice (Gondos et al., 1971; Russe, 1983). 
In humans maternal E2 levels are rising at the time of primordial follicle formation and in 
cows levels are low prior to follicle formation suggesting maternal circulating E2 is not 
the source of E2 in these species. In addition, fetal bovine ovaries produce E2 and P4, 
which inhibit precocious follicle formation (Nilsson and Skinner, 2009; Yang and 
Fortune, 2008). Furthermore, while the majority of follicles form after birth in the mouse, 
some oocytes are found in follicles as early as two days before birth (Pepling et al., 
2010). These findings necessitate a revision in the endocrine model of follicle formation 
in mice. 
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       Steroid hormones are synthesized from precursors starting with cholesterol in the 
mitochondria (Miller, 2013). In the final step of E2 synthesis, androgens are converted to 
estrogens by the enzyme aromatase encoded by the Cyp19a gene (Stocco, 2008). In adult 
ovaries, E2 is synthesized in granulosa cells of preovulatory follicles (Stocco, 2012). 
Aromatase has also been detected in fetal mouse and human ovaries and E2 has been 
proposed to play a role in ovarian fetal development (Fowler et al., 2011; Greco and 
Payne, 1994). Synthesis of P4 occurs earlier than synthesis of E2 in the biosynthetic 
pathway and is synthesized from its precursor by 3-beta-hydroxysteroid dehydrogenase 
(3βHSD) (Miller and Auchus, 2011). There are several 3βHSD isoforms in the mouse 
encoded by the HSD3B1-6 genes. Similar to aromatase, 3βHSD has been detected in the 
fetal ovary (Payne et al., 1997).                  
       The goal of the current study was to investigate the source of steroid hormones 
during the fetal period in mice before cyst breakdown and follicle formation. Our 
hypothesis was that fetal ovaries synthesize their own steroid hormones to regulate 
oocyte development. We first measured levels of maternal circulating hormones as well 
as hormone levels in fetal ovaries. Second, we investigated the presence of the necessary 
components of steroid biosynthetic machinery to facilitate hormone production in fetal 
ovaries. Finally, we examined perinatal oocyte development in ovaries where hormone 
production is blocked by inhibitors. These studies will enrich our understanding of the 
factors regulating fetal oocyte development in mice providing useful insights in 
ameliorating human infertility. 
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2.3. MATERIALS AND METHODS 
2.3.1. Animals 
        Adult male and female CD1 outbred mice were obtained from Charles River 
Laboratories (Wilmington, MA, USA). They were maintained in accordance with the 
policies of Syracuse University’s Institutional Animal Care and Use Committee. Mice 
were housed and bred in a controlled photoperiod (14 h light, 10 h dark), temperature 
(21-22°C), and humidity with food and water available ad libitum. Timed pregnant 
females were either generated by setting up matings in house or purchased timed 
pregnant from Charles River Laboratories. For in house matings, CD1 females were 
mated with males of the same strain and checked daily for vaginal plugs. Noon on the 
day of vaginal plug detection was designated as 0.5 dpc. Birth usually occurred at 19.5 
dpc and was designated as postnatal day (PND) 1. Pregnant mice were euthanized by 
CO2 asphyxiation for fetal ovary collection. For neonatal ovary collection, female pups 
were sacrificed by decapitation on the appropriate day. 
 
2.3.2. Steroid assays 
       Maternal and perinatal blood were collected for evaluation of estradiol and 
progesterone content in the circulation. Whole blood was allowed to clot briefly at room 
temperature before centrifugation at 10,000g for 15 minutes. The serum was then 
collected for assays. Perinatal ovaries were harvested and homogenized in phosphate 
buffered saline (PBS) for measurement of tissue steroid hormone levels. Steroid hormone 
radioimmunoassays (RIAs) were performed on serum samples and ovarian homogenates 
by the Assay Core Laboratory, Center for Reproductive Biology, Washington State 
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University.  An organic phase extraction procedure was used to concentrate samples for 
the assays. The extracted samples were then reconstituted into the same buffer as used 
with the assay standards. The steroid recovery was greater than 95% and the linearity was 
within the acceptable criteria for the Assay Core Laboratory. Intra assay coefficient of 
variation (CV) for the estradiol assay (Kit KE2D1, Siemens Healthcare Diagnostics Inc., 
Los Angeles, CA) was 5.6% and for the progesterone assay (Kit TKPG1, Siemens 
Healthcare Diagnostics Inc., Los Angeles, CA) was 3.8%. 
 
2.3.2. RNA isolation 
       Fetal (13.5 dpc-18.5 dpc) and neonatal (PND1-PND3) ovaries were dissected and 
stored in RNAlater at -80°C until further use. Total RNA was isolated using an RNeasy 
Mini kit (n=3; approximately 50 neonatal or 100 fetal ovaries were used per pool). 
Ovaries were briefly lysed, homogenized using a motor pestle and then applied to a 
QIAshredder column. The ovarian tissue sample in the QIAshredder column was then 
centrifuged at 14,000 g for 2 minutes. To isolate the RNA, the resulting flow-through was 
applied to an RNeasy mini column allowing the RNA to bind to the filter cartridge. RNA 
was eluted by washing from the filter and was concentrated using an RNeasy MinElute 
kit. Isolated RNA was briefly applied to an RNeasy MinElute spin column and washed, 
then the RNA was eluted using 14 µl of RNase-free water. The RNA concentration in the 
elutant was determined using an ND-1000 Spectrophotometer (λ= 260/280 nm; Nanodrop 
Technologies, Inc., Wilmington, DE).  
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2.3.3. First strand cDNA synthesis and real-time polymerase chain reaction (PCR) 
       Total RNA (0.5 µg) was reverse transcribed using the Superscript III One-Step RT-
PCR System into cDNA. cDNA was diluted in RNase-free water (1:25). 2µl of diluted 
cDNA was amplified on a Rotor-Gene 3000 using QuantitectTM SYBR Green PCR kit 
and custom designed primers for Aromatase (Cyp 19) (forward primer: 5' 
GGCCAAATAGCGCAAGATGTTCTT 3'; reverse primer: 5' 
GACTCTCATGAATTCTCCATACATCT 3'; NCBI Genbank accession number 
NM_007810), 3βHSD (forward primer: 5' CTC TCT TTA ACC GCC ACT CG 3'; 
reverse primer: 5' TAC CTG CCC TTT TTC CAT CA 3'; NCBI Genbank accession 
number NM_013821) and β-actin (forward primer: 5´ AGT GTG ACG TTG ACA TCC 
GTA 3´; reverse primer: 5´ GCC AGA GCA GTA ATC TAA TTA T 3´; NCBI Genbank 
accession number NM_007393). The cycling program consisted of a 15 min hold at 95°C 
and 45 cycles of: denaturing at 95°C for 15 s, annealing at 58°C for 15 s, and extension at 
72°C for 20 s at which point data were acquired. Determination of product melt 
conditions were done using a temperature gradient from 72°C to 99°C with a 1°C 
increase at each step. β-actin expression remained constant across all ages and each 
sample was normalized to β-actin before quantification. 
 
2.3.4. Protein Isolation 
       Ovaries were lysed in lysis buffer (1% Triton X-100, 50mM HEPES, 150mM NaCl, 
10% glycerol, 50mM NaF, 2mM EDTA and 0.1% SDS). Supernatants were collected 
after centrifugation and stored at -80°C until further use. The protein content was 
quantified using Bradford’s Reagent (Biorad). Protein concentrations were calculated 
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from a BSA protein standard curve. Emission absorbance values were detected with a λ= 
595 nm excitation with a microplate reader (Beckman Coulter, Fullerton, CA).  
 
2.3.5. Western blot analysis 
       Proteins were separated on 10% SDS-PAGE gels (30 µg protein/lane) for each time 
point and subsequently electroblotted onto Immobilon-PVDF membranes (Millipore). 
For 3βHSD, 5% milk in PBS with 0.05% Tween 20 (PBST) was used as the blocking 
agent. Blots were blocked overnight while shaking at 4°C and exposed to an antibody 
against 3βHSD (K0607, Cosmo Bio, Carlsbad, CA) at a dilution of 1:100. Blots were 
stripped using a stripping buffer (0.25M Tris pH=6.8, 40% glycerin, 20% β-
mercaptoethanol and 10% SDS) and then reprobed using an antibody against aromatase 
(ab35604, Abcam Inc., Cambridge, MA) diluted 1:100. For aromatase, the blots were 
blocked overnight with shaking at 4°C in 5% BSA in Tris buffered saline with 0.05% 
Tween 20 (TBST). The membranes were incubated with primary antibodies overnight at 
4oC in their respective blocking agents. Western blots were detected by 
chemiluminescence using Pierce (Rockford, IL) HRP-conjugated secondary IgG 
antibodies (1:10,000) in 5% milk in PBST at room temperature for 1 hr. For aromatase, 
the HRP-conjugated secondary antibody used was goat α-rabbit IgG (Pierce, catalog # 
31460) and for 3βHSD, the secondary antibody used was rabbit α-goat IgG (Pierce, 
catalog # 31402) The membrane was then washed three times by PBST and the signal 
visualized using Bio-Rad ChemiDocTM XRS+ system. Blots were stripped and reprobed 
for GAPDH (sc166545, Santa Cruz Biotechnology, Inc., La Jolla, CA) diluted 1:5000 as 
a loading control. For quantitative analysis, blot images were saved as PICT files using 
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Science Lab 99 Image Gauge software version 3.3 (Fujifilm Inc.) and pixel intensities 
were measured. Protein levels were normalized to the corresponding GAPDH protein 
levels and expressed as relative percentage of the earliest age, 15.5 dpc which was set to 
100%). 
 
2.3.6. Whole-mount immunohistochemistry and fluorescence microscopy 
       Ovaries were dissected and fixed in 5% EM-grade paraformaldehyde (Ted Pella, 
Inc., Redding, CA) in PBS for 1 h at room temperature followed by several washes in 5% 
BSA and 0.1% Triton X-100 in PBS. Whole ovaries were immunostained as previously 
described (Murphy et al., 2005). Signal transducer and activator of transcription (STAT)-
3 (C20) antibody, (sc-482, Santa Cruz Biotechnology, La Jolla, CA) was used as an 
oocyte marker at a dilution of 1:500 (Murphy et al., 2005). Propidium iodide (P3566, 
Invitrogen, Carlsbad, CA) was used to label nuclei. Anti-aromatase antibody (ab18995, 
Abcam Inc., Cambridge, MA) and anti-3βHSD (P-18) antibody (sc-30820,Santa Cruz 
Biotechnology, La Jolla, CA) were both used at a 1:100 dilution. For double labeling of 
mitochondria and endoplasmic reticulum (ER) with anti-3βHSD antibodies, cytochrome 
C (ab 18738) antibody and calnexin (ab22595) antibody (Abcam Inc., Cambridge, MA) 
were used. Secondary antibodies, donkey anti-rabbit Alexa 488 (A-21206) and donkey 
anti-goat Alexa 568 (A-11057,Invitrogen,	  Carlsbad, CA) were used at a dilution of 1:200. 
TOTO-3 (T3604, Life Technologies, Carlsbad, CA) was used as a nuclear marker in case 
of double labeling. Samples were imaged on a Zeiss LSM 710 confocal microscope (Carl 
Zeiss MicroImaging, Inc., Thornwood, NY). 
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2.3.7. In vitro ovary organ culture  
       Letrozole (Sigma Chemical Co., St. Louis, MO) and trilostane (a gift from Dr. Gavin 
Vinson, Queen Mary, University of London) were both dissolved in dimethylsulfoxide 
(DMSO) at a concentration of 0.1 M. They were added to culture media to achieve the 
desired final concentrations (see below). DMSO was added to media at the same percent 
as the chemical to serve as vehicle control. Ovaries were cultured in 4-well culture plates 
in drops of media on 0.4 µM floating filters (Millicell CM; Millipore Corp., Bedford, 
MA) in 0.4 ml DMEM-Ham’s F-12 media supplemented with penicillin-streptomycin, 
5X ITS-X (Life Technologies, Inc., Grand Island, NY), 0.1% BSA, 0.1% albumax, and 
0.05 mg/ml L-ascorbic acid. Ovaries were placed in culture at 16.5 dpc and exposed daily 
to letrozole, trilostane or both inhibitors for 5 days (equivalent to PND3 in vivo) at 10-10, 
10-8, 10-6 or 10-4 M or in DMSO alone as a vehicle control (n=5-8 ovaries per treatment 
group). Ovaries from both control and treatment groups were processed for whole mount 
immunocytochemistry. 
 
2.3.8. Analysis of cyst breakdown, primordial follicle assembly and follicle development 
        Whole ovaries labeled with an antibody against STAT3, a specific marker for germ 
cells (Murphy et al., 2005) and propidium iodide as nuclei marker were imaged using 
confocal microscopy. For each ovary, two cores were randomly selected and visualized 
(Jones and Pepling, 2013). A core was defined as a region of 134.7 µm x 134.7 µm 
consisting of four optical sections at four different depths of the ovary with each optical 
section 15 µm apart. To ensure ovarian development was assessed across all regions of 
the ovary, the first section was typically chosen at the outer cortex and the last section 
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was at the medullar region. Thus, for each ovary, a total of eight optical sections were 
analysed. To determine whether or not oocytes were in cysts, a z-stack of images each 
1µm apart was obtained with five images above the section and five images below the 
section being analyzed. The same procedure was repeated for each of the four optical 
sections in a core. This allowed us to determine whether an oocyte was part of a germ cell 
cyst above or below the plane of focus. Oocytes were considered unassembled or in cysts 
if STAT3 antibody labeling showed oocytes having continuous cytoplasm. The oocytes 
surrounded by a layer or layers of granulosa cells were considered to be in follicles. 
       The number of oocytes in follicles relative to the total number of oocytes was 
determined for each ovary and reported as percent single oocytes. Follicle development 
was determined by counting the number of primordial (oocyte surrounded by several 
flattened granulosa cells) and primary follicles (oocyte surrounded by one layer of 
cuboidal granulosa cells) present in relation to the total number of follicles counted and 
reported as percent primordial or primary follicles. More advanced staged follicles were 
not observed. 
 
2.3.9. Statistical analysis 
       Statistical analysis of qPCR data was performed using Statview 5.0.1 (SAS Institute 
Inc., Cary, NC). Gene expression from 13.5 dpc to PND3 was evaluated by one-way 
ANOVA followed by Bonferroni-Dunn’s post hoc test (P< 0.0014). Analysis of fetal 
ovary hormone levels and effects of hormone inhibitors on oocyte development were 
performed using GraphPad Prism 6 (GraphPad Software Inc., San Diego, CA). One-way 
ANOVA followed by Newman-Keuls multiple comparison test was used to determine if 
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there were significant differences in hormone levels of fetal and neonatal ovaries. One-
way ANOVA followed by Dunnett’s post hoc test (P< 0.05) was used to assess the 
effects of letrozole and trilostane treatments on oocyte number, percent single oocytes 
and follicle development. Percentage data by nature is not normal and arcsine 
transformation on the percentage data was performed before doing statistical analysis. All 
results are presented as mean ± SEM of nontransformed data. 
 
2.4. RESULTS 
2.4.1. Circulating maternal and perinatal steroid hormone levels during gestation 
       Our initial model was that steroid hormones in the maternal circulation maintained 
oocytes in cysts in female fetuses. Germ cell cysts begin to break down at 17.5 dpc and 
thus we expected maternal steroid hormone levels to drop at that time. RIAs were 
performed with maternal serum to test whether the drop in maternal circulating hormones 
correlated with cyst breakdown. E2 levels in the maternal circulation rose from 5 pg/ml to 
25 pg/ml between 13.5 and 17.5 dpc (Figure 2.1A). However, maternal E2 levels did not 
drop until the day of birth which is two days after cysts begin to break down. P4 levels 
were steady from 13.5 to 16.5 dpc and began to drop at 17.5 dpc. Thus unlike E2, the 
drop in P4 levels appeared to correlate with the beginning of cyst breakdown. 
       Figure 2.1B shows the steroid hormone levels in the perinatal circulation from 17.5 
dpc to PND7.  E2 levels were high at 17.5 dpc and continually dropped until birth.  P4 
levels rose slightly from 17.5 dpc to 18.5 dpc and then began to drop from PND1 to 
PND3. After PND3 the levels were constant. The source of the steroid hormones in the 
perinatal circulation could be maternal, fetal or both.  
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2.4.2. Aromatase and 3βHSD present in perinatal ovaries 
       To investigate the possibility of a fetal contribution to steroid hormone levels, the 
presence of steroidogenic enzymes were examined in developing ovaries using qPCR and 
Western blotting. Figure 2.2A and 2.2B shows the relative changes in aromatase and 
3βHSD mRNA levels from 13.5 dpc to PND3 as determined by qPCR analysis. 
Aromatase mRNA levels are relatively low from 13.5 to 15.5 dpc and then peak at 16.5 
dpc (Figure 2.2A). The aromatase levels then drop at 17.5 dpc and do not significantly 
increase thereafter. Figure 2.2B shows the relative changes in 3βHSD mRNA levels from 
13.5 dpc to PND3. The mRNA levels are relatively high from 13.5 dpc to 15.5 dpc 
followed by a dramatic drop. Thus, both ovarian aromatase and 3βHSD mRNA levels 
drop just before the beginning of cyst breakdown and follicle formation. Aromatase 
protein was detected by Western blotting in ovaries from 15.5 dpc to 18.5 dpc (Figure 
2.2C). A 50 kd protein was detected at all timepoints. The presence of 3βHSD protein 
was also detected by Western blotting in 15.5 dpc to 18.5 dpc ovaries (Figure 2.2D). A 
42 kd band corresponding to 3βHSD was observed in all four samples. 
       To determine what cell types express aromatase and 3βHSD protein in fetal ovaries, 
whole mount immunocytochemistry was performed on ovaries from 15.5 dpc to 18.5 dpc 
(Figures 2.3 and 2.4). At 15.5 dpc aromatase was detected in all ovarian cells (Figure 
2.3A-C). Aromatase protein appears to be expressed more strongly in oocytes than in 
somatic cells at 16.5 dpc (Figure 2.3D-F), 17.5 dpc (Figure 2.3G-I) and 18.5 dpc 
(Figure 2.3J-L). Like aromatase, 3βHSD protein was found in all ovarian cells at 15.5 
dpc (Figure 2.4A-C). At 16.5 dpc, 3βHSD appears to be expressed more strongly in 
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oocytes than somatic cells and is much stronger in some of the oocytes (Figure 2.4D-F). 
This trend continues at 17.5 dpc (Figure 2.4G-I) and 18.5 dpc (Figure 2.4J-L). In 
addition, at 18.5 dpc, in oocytes that are strongly labeled for 3βHSD, the protein is 
detected in oocyte cytoplasm with a very speckled appearance. The speckles are likely 
mitochondria as 3βHSD is known to be expressed in the mitochondria and also in the 
endoplasmic reticulum (Pelletier et al., 2001). To determine if the speckled bodies 
correspond to either mitochondria or ER, we co-labeled neonatal ovaries with 3βHSD 
and either mitochondrial marker (Figure 2.5A-D) or an ER marker (Figure 2.5E-H). 
While there is some overlap of 3βHSD with mitochondria and with ER they do not 
completely correspond with one another. 
 
2.4.3. E2 and P4   found locally in perinatal ovaries 
       Steroid assays were performed on ovarian tissue to determine the levels of E2 and P4 
present in perinatal ovaries. Ovarian E2 was detected from 15.5 dpc to 18.5 dpc and again 
from PND5 to PND7 (Figure 2.6A). There was significant increase in the levels of E2 at 
PND6 and PND7. Figure 2.6B focuses only on the perinatal time-period from 15.5 dpc 
to PND3 for ovarian E2 levels. Ovarian E2 was detected at 15.5 dpc and 16.5 dpc with an 
increase at 17.5 dpc. The E2 level decreased at 18.5 dpc though the difference from 17.5 
dpc was not statistically different. E2 was undetectable between PND1 and PND3. 
Ovarian P4 was detected at all time-points from 15.5 dpc to PND7 (Figure 2.6C). Figure 
2.6D focuses on the perinatal time period of 15.5 dpc to PND3 for intraovarian P4 levels.  
P4 levels fluctuate from 15.5 dpc to PND3 but the differences were not significant. For 
both E2 and P4, the statistically significant increase at PND7 correlates to previous studies 
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showing that on gonadotrophin surge starting around PND7, cultured mouse ovaries have 
the ability to synthesize significant levels of  steroid hormones (Fortune and Eppig, 
1979). 
2.4.4. Effects of inhibiting E2 and P4 production in the fetal ovary 
       Our hypothesis is that E2 and P4 produced in fetal ovaries are important for 
regulating cyst breakdown. To test this we examined the effects of blocking E2 and P4 
production in organ culture. We expected that cyst breakdown and associated oocyte loss 
would occur prematurely when E2 or P4 synthesis was inhibited. We used a series of 
doses of the aromatase inhibitor, letrozole to decrease the production of E2. The IC50 of 
letrozole is 2 x 10-8 M for hamster ovaries cultured in vitro (Bhatnagar et al., 1990). We 
treated fetal mouse ovaries with 10-10 M (100 fold below the IC50), 10-8 M (half of the 
IC50), 10-6 M (50 times the IC50) and 10-4 M (5,000 times the IC50) letrozole. Ovaries 
were collected at 16.5 dpc, when E2 levels were expected to be high, and cultured for 5 
days. We found that the percent of single oocytes (a measure of cyst breakdown) was not 
significantly different from control ovaries at any of the concentrations tested (Figure 
2.7A). However, at the lowest concentration of letrozole (10-10 M) the number of oocytes 
per section was significantly lower than in controls (Figure 2.7B). Follicle development 
was not affected by letrozole treatment with no significant difference in the percent of 
growing follicles between the control and all four concentrations of letrozole used 
(Figure 2.7C). To block P4 production we used trilostane, a 3βHSD inhibitor (Figure 
2.8). The IC50 of trilosane in rat sciatic nerves has been reported as 4 x 10-6 M (Coirini et 
al., 2003).  Here, we used the same range of concentrations as for aromatase and similar 
results were obtained except that oocyte number per section was reduced at 10-8 M and 
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10-4 M but not at 10-10 M or 10-6 M (Figure 2.8B). We used letrozole and trilostane 
together to block production of both E2 and P4 and found that oocyte number was reduced 
at all concentrations tested but cyst breakdown and follicle development were not 
significantly different from controls (Figure 2.9). 
 
2.5. DISCUSSION 
       We found that the drop in maternal P4 but not E2 corresponded to the initiation of 
cyst breakdown. This suggested that there was another source of hormones possibly the 
fetal ovary as in the bovine model (Nilsson and Skinner, 2009; Yang and Fortune, 2008). 
Here we showed that the corresponding mRNA and protein of enzymes necessary for the 
production of E2 and P4, aromatase and 3βHSD, respectively were present in fetal 
ovaries. In addition, we detected E2 and P4 locally in fetal ovaries. Finally, we carried out 
inhibitor studies blocking aromatase and 3βHSD in organ culture and demonstrated that 
oocyte number was reduced at certain inhibitor concentrations for each hormone while 
oocyte number was reduced at all concentrations when both inhibitors were used.  
       Our data bring into question the idea that maternal hormones are the only source of 
hormones that regulate fetal ovary development.  We previously showed that some 
follicles assemble before birth during the fetal period in mice and the timing of follicle 
assembly is more similar to the bovine model (Pepling et al., 2010). Fetal bovine ovaries 
synthesize their own E2 and P4 (Nilsson and Skinner, 2009; Yang and Fortune, 2008) and 
here, we detected E2 and P4 in fetal mouse ovaries as well. Supporting the idea that fetal 
mouse ovaries can produce steroid hormones, we also detected the enzymes responsible 
for final steps of E2 and P4 biosynthesis. Aromatase mRNA levels peaked at 16.5 dpc and 
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then declined correlating with start of cyst breakdown. Likewise, 3βHSD mRNA levels 
were high from 13.5 to 15.5 dpc and then declined. In the steroid biosynthetic pathway, 
3βHSD acts upstream of aromatase and synthesizes the precursor for E2 production 
(Miller and Auchus, 2011). High levels of 3βHSD from 13.5 to 15.5 dpc may allow the 
synthesis of E2 precursors before aromatase peaks at 16.5 dpc. Protein levels of these two 
enzymes were also detected in ovaries but did not fluctuate across timepoints.  
       E2 peaked one day after aromatase at 17.5 dpc and then dropped at 18.5 dpc, though 
this was not a statistically significant decrease and P4 while present did not significantly 
change across timepoints. Likewise, P4 levels produced by fetal bovine ovaries in culture 
did not fluctuate over time (Yang and Fortune, 2008). However, in studies where P4 
levels were determined in fetal bovine tissue, levels dropped right at the time when 
follicles were forming (Nilsson and Skinner, 2009). One reason that fetal E2 and P4 levels 
don’t correlate with follicle formation in some studies is that proteins that bind to steroid 
hormones such as α-fetoprotein might also be present and limit hormone activity or 
availability. Another possibility is that the hormones present in fetal ovaries come from 
multiple sources including local hormone production, maternal circulation or from the 
placenta. 
       Steroid hormones can promote or inhibit follicle formation depending on species. 
This could be due to species differences in response to steroid hormone signaling. 
Alternatively, a basal low concentration of steroid hormones might be necessary for 
follicle formation and only at high concentrations have inhibitory effects (Kezele and 
Skinner, 2003; Wang and Roy, 2007). In mice, exposure to exogenous E2 and P4 blocks 
primordial follicle formation (Chen et al., 2007; Kezele and Skinner, 2003). Similarly, in 
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cultured fetal bovine ovaries follicle formation is blocked by E2 and P4 (Nilsson and 
Skinner, 2009; Yang and Fortune, 2008). However, in hamsters, E2 promotes follicle 
formation (Wang and Roy, 2007). In baboons, follicle formation is disrupted if E2 
production is inhibited suggesting that normally as in the hamster, E2 promotes follicle 
formation (Zachos et al., 2002). Further studies are necessary to understand species 
differences in response to steroid hormones. 
       We found that inhibiting synthesis of E2 and P4 in organ culture reduced the number 
of oocytes per section but did not alter cyst breakdown and follicle formation. We 
expected that cyst breakdown would be accelerated based on the model that a drop in E2 
and P4 would cause cyst breakdown and associated oocyte loss to begin. Our data raise 
the possibility that in mouse, estrogen is important for oocyte survival during fetal 
ovarian development but is not directly involved in cyst breakdown. Our results are 
similar to data obtained from studies of mice lacking aromatase (Britt et al., 2004). 
Although fetal and neonatal oocyte development was not examined, aromatase knockout 
mice had fewer primordial and primary follicles at 10 weeks of age. Since earlier 
timepoints were not examined it is not known when this loss occurred or if follicle 
formation was affected. Fetal ovary development has been examined in baboons treated 
with letrozole during late gestation (Zachos et al., 2002). Female fetuses collected from 
mothers treated with letrozole had a reduced number of primordial follicles compared to 
controls. However, unlike our studies, an increased number of interfollicular nests 
containing oocytes that are presumably in cysts were found suggesting that inhibition of 
E2 synthesis led to a block in cyst breakdown. An increase in primary-like follicles was 
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also observed. It is not known if the total oocyte number was affected because the overall 
number of oocytes was not determined. 
       Many questions remain regarding the role of steroid hormones in the fetal ovary as 
well as the signaling mechanisms involved. It is unclear what receptors are important 
during fetal development and future studies identifying the relevant receptors are 
necessary. It will also be informative to investigate cyst breakdown and follicle formation 
in aromatase knockout animals. Understanding the role of steroid hormone signaling in 
fetal oocyte differentiation will elucidate mechanisms leading to formation of the 
primordial follicle pool and thus fertility. 
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2.6. Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Maternal and perinatal circulating levels of E2 and P4 :  (A) Maternal 
serum levels of E2 measured in pg/ml and P4 measured in ng/ml during gestation and 
after birth (n ≥ 5). (B) Perinatal serum levels of E2 measured in pg/ml and P4 measured in 
ng/ml (n=3). Data are presented as the mean ± SEM. 
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Figure 2.2. mRNA and protein levels of steroidogenic enzymes in perinatal mouse 
ovaries:  Aromatase (A) and 3βHSD (B) mRNA levels during the perinatal period. 
Levels of aromatase and 3βHSD mRNAs are normalized to the levels of mRNA for a 
housekeeping gene, β-actin in the same sample. The normalized values are expressed 
relative to the mRNA levels at 13.5 dpc with 13.5 dpc set at 1. * indicates a significant 
difference as determined by one-way ANOVA followed by a Bonferroni-Dunn’s post hoc 
test (p< 0.0014; n= 3).Western blot analysis of aromatase and 3βHSD in fetal ovaries (C-
F). Ovary extracts from 15.5 dpc, 16.5 dpc, 17.5 dpc and 18.5 dpc were probed for (C) 
aromatase (50 kd) or (E) 3βHSD (42 kd). All extracts were also probed for the loading 
control GAPDH (38 kd). Quantification of aromatase (D) or 3βHSD (F) protein 
expression normalized to GAPDH and reported as % relative pixel intensity compared to 
15.5 dpc set at 100%. 
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Figure 2.3. Expression of aromatase protein in the fetal ovary. 
Confocal sections from 15.5 dpc (A–C), 16.5 dpc (D–F), 17.5 dpc (G–I) and 18.5 dpc 
(J–L) ovaries labeled for aromatase (green) (A, D, G and J) and the nuclear marker 
propidium iodide (red) (B, E, H and K) with overlay shown in C, F, I and L. White 
arrowheads indicate oocytes, white arrows indicate somatic cells. Scale bar, 20 µm. 
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Figure 2.4. Expression of 3βHSD protein in the fetal ovary.  Expression of 3βHSD 
protein in the fetal ovary. Confocal sections from 15.5 dpc (A–C), 16.5dpc (D–F), 17.5 
dpc (G–I) and 18.5 dpc (J–L) ovaries labeled for 3βHSD (green) (A, D, G and J) and 
thenuclear marker propidium iodide (red) (B, E, H and K) with overlay shown in C, F, I 
and L. White arrowheads indicate oocytes (upper arrowhead in D-F and J-L indicates a 
strongly labeled oocyte while the lower arrowhead indicates a weakly labeled oocyte), 
white arrows indicate somatic cells. Scale bar, 20µm. Inset shown in panel L is an 
enlarged view of the area within the white dashed box. 
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Figure 2.5. Colabeling of 3βHSD and mitochondria or ER. Confocal sections from a 
PND6 ovary (A-D) labeled for the mitochondrial marker CYTC (green) (A), 3βHSD 
(red) (B), overlay (C) and DNA marker TOTO3 (white) (D). Confocal sections a PND5 
ovary (E-H) labeled for the ER marker Calnexin (green) (E), 3βHSD (red) (F), overlay 
(G) and the DNA marker TOTO3 (white) (H). Scale bar, 10 µm. 
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Figure 2.6. Concentration of E2 and P4 in fetal and neonatal ovaries.  
(A) E2 levels (pg/mg protein) in ovaries from 15.5 dpc to PND7 (B) E2 levels (pg/mg protein) in 
ovaries from 15.5 dpc to PND3 (C) P4 levels (ng/mg protein) in ovaries from 15.5 dpc to PND7 
and (D) P4 levels (ng/mg protein) in ovaries from 15.5 dpc to PND3 (n=3, each n~ 300 ovaries). 
Data are presented as the mean ± S.E.M. ND- Not Detected. Different letter subscripts indicate a 
significant difference. * indicates PND7 significantly different from other ages. (One-way 
ANOVA followed by Newman-Keuls multiple comparison test, P<0.05).  
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Figure 2.7. Effects of inhibiting aromatase in fetal ovaries.  
(A) percent single oocytes (B) number of oocytes and (C) percent primordial and primary 
follicles relative to the total number of follicles per confocal section in 16.5 dpc ovaries 
cultured with the aromatase inhibitor letrozole or in control media for 5 days. Data are 
presented as the mean ± S.E.M. *Indicates a significant difference between control and 
treated ovaries (One-way ANOVA followed by Dunnett’s post hoc test, P<0.05). n ≥ 5 
ovaries per group. 
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Figure 2.8. Effects of inhibiting 3βHSD in fetal ovaries. 
Effects of inhibiting 3βHSD in fetal ovaries. (A) percent single oocytes, (B) number of oocytes 
nd (C) percent primordial and primary follicles relative to the total number of follicles per 
confocal section in 16.5 dpc ovaries cultured with the 3βHSD inhibitor trilostane or in control 
media for 5 days. Data are presented as the mean ± S.E.M. 
 *Indicates a significant difference between control and treated ovaries (One-way ANOVA 
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Figure 2.9. Effects of inhibiting aromatase and 3βHSD in fetal ovaries. 
(A) percent single oocytes (B) number of oocytes and (C) percent primordial and primary 
follicles relative to the total number of follicles per confocal section in 16.5 dpc ovaries 
cultured with the aromatase inhibitor letrozole and the 3βHSD inhibitor trilostane or in 
control media for 5 days. Data are presented as the mean ± S.E.M.  
*Indicates a significant difference between control and treated ovaries (One-way 
ANOVA followed by Dunnett’s post hoc test, P<0.05). n ≥ 5 ovaries per group. 
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Chapter 3 
The Role of Steroid Hormones in Murine Oocyte 
Meiotic Progression 
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3.1. ABSTRACT 
        In mammalian females, reproductive capacity is determined by the size of the 
primordial follicle pool. During embryogenesis, oogonia divide by mitosis but 
cytokinesis is incomplete so that the oogonia remain connected in germ cell cysts. 
Oogonia begin to enter meiosis at approximately 13.5 days postcoitum (dpc) and over the 
next several days, oocytes progress through the stages of meiotic prophase I and arrest in 
the diplotene stage. At the same time, germ cell cysts begin to break down and individual 
oocytes become surrounded by granulosa cells forming primordial follicles. In rats, 
inhibition of a synaptonemal complex protein caused premature arrival at the diplotene 
stage and premature assembly of primordial follicles suggesting that diplotene arrest 
might trigger primordial follicle formation. Cyst breakdown and primordial follicle 
formation are blocked by exposure to exogenous hormones but effects on the timing of 
diplotene arrest are unclear. Here, we asked: (1) if oocytes were required to be in 
diplotene before follicles formed, (2) if all oocytes within a germ cell cyst arrested at 
diplotene synchronously, and (3) if steroid hormones could affect progression through 
prophase I of meiosis. Meiotic stage and follicle formation were assessed in histological 
sections. We found that oocytes within primordial follicles were at diplotene or pre-
diplotene stages suggesting that meiosis and primordial follicle formation are 
independent. In addition, we found that germ cell cysts contain oocytes at both diplotene 
and pre-diplotene stages. To determine if steroid hormones affect the rate of progression 
to the diplotene stage, 17.5 dpc ovaries were placed in organ culture with control media 
or media containing estradiol, progesterone or both hormones. We found that 
progesterone delayed meiotic progression.  
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3.2. INTRODUCTION 
       In female mammals, reproductive capacity is determined at birth by the non-
renewable pool of primordial follicles present representing the total population of germ 
cells available for reproductive purposes (Pepling, 2006). In mice, the primordial germ 
cells migrate to the genital ridge and divide by mitosis until 13.5 days postcoitum (dpc) 
(McLaren and Monk, 1981). During these divisions the germ cells are known as oogonia 
and develop in germ cell cysts due to incomplete cytokinesis following each cell cycle 
(Pepling, 2006). Oogonia start to enter meiosis at approximately 13.5 dpc and are then 
referred to as oocytes (McLaren, 2000b). Oogonia do not appear to enter meiosis 
synchronously (Borum, 1961; Peters, 1970). However, meiosis proceeds from anterior to 
posterior suggesting that local factors diffuse from the mesonephros at the anterior side of 
the ovary to promote meiosis (Bullejos and Koopman, 2004). Most germ cells are in 
meiosis by 15.5 dpc (Borum, 1961). After entering meiosis oocytes progress through the 
initial stages of meiotic prophase I and remain arrested at diplotene stage until just prior 
to ovulation. Some oocyte arrive at the diplotene stage by 17.5 dpc but it takes several 
days until all oocytes are in diplotene (Borum, 1961).  
       Mutations in genes such as disrupted meiotic cDNA 1 (Dmc1) and meiosis-specific 
sporulation protein (Spo11) responsible for the initial stages of meiosis result in loss of 
oocytes and an inability to form follicles which ultimately gives rise to sterility 
(Villeneuve and Hillers, 2001). This time point is marked by the expression of 
synaptonemal complex proteins (SYCPs) that make up the synaptonemal complex which 
is required for DNA synapsis and meiotic recombination between homologous 
chromosomes. In rats, it was found that inhibition of SYCP1 accelerated the attainment 
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of the diplotene stage along with premature assembly of those oocytes into primordial 
follicles (Paredes et al., 2005). A large number of oocytes that fail to attain diplotene 
arrest but continue on through diakinesis are lost by attrition during early folliculogenesis 
(Ohno and Smith, 1964). A crucial factor for the survival of germ cells may be their 
ability to be enclosed within follicles (Byskov, 1986). This evidence reflects the 
possibility of a relation between two temporal events during mouse oogenesis, diplotene 
stage and primordial follicle formation. 
       Both estradiol (E2) and progesterone (P4) in mouse can delay cyst breakdown and 
primordial follicle formation (Chen et al., 2007). Estrogens have also been shown to 
affect meiotic progression of oocytes. Studies were performed using a synthetic estrogen, 
bisphenol A (BPA) on pregnant mice during mid-gestation. The oocytes from the female 
fetuses of exposed mothers had synaptic defects and recombination aberrations. In adults, 
those aberrations gave rise to aneuploid eggs and embryos (Susiarjo et al., 2007). In 
cattle, it is thought that primordial follicles cannot be activated until after the oocyte 
reaches diplotene arrest. In vitro treatment of bovine ovaries with estradiol (E2) or 
progesterone (P4) decreased the number of follicles that were activated and may affect 
progression to the diplotene stage (Yang and Fortune, 2008).  
       MSY2 is a germ cell specific maternal mRNA binding protein and is 
developmentally regulated in mouse oocytes and spermatocytes. In oocytes, it is 
upregulated as the oocytes enter the diplotene stage and persists until after fertilization 
(Gu et al., 1998). Its role as a diplotene arrest marker was shown in cattle when the 
mRNA levels for Ybx2 increased 2.3 fold after Day 141 of gestation when primordial 
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follicles are activated and form primary follicles containing oocytes at the diplotene stage 
(Yang and Fortune, 2008). 
       The main objectives of the present study were to determine if diplotene arrest is 
linked with primordial follicle formation. Secondly, we wanted to elucidate the role of 
steroid hormone signaling in meiotic progression of oocytes. The molecular mechanisms 
involved in fetal ovarian development are still poorly understood. Future studies 
elucidating events during fetal ovarian development will increase our understanding of 
the factors that control oocyte quality and quantity and thus help in improvement of 
currently available infertility treatments. 
 
3.3. MATERIALS AND METHODS 
3.3.1. Animals 
       Adult CD1 male and female outbred mouse strain was obtained from Charles River 
Laboratories (Wilmington, MA, USA). They were maintained in accordance with the 
policies of Syracuse University’s Institutional Animal Care and Use Committee. Mice 
were housed and bred at a controlled photoperiod (14 h light, 10 h dark), temperature 
(21-22° C), and humidity with food and water available ad libitum. CD1 females were 
mated with males of same strain and checked daily for vaginal plugs. The noon on the 
day of vaginal plug detection was designated as 0.5 dpc. Birth usually occurred at 19.5 
dpc and was designated as postnatal day (PND) 1. Pregnant mice were euthanized by CO 
2 asphyxiation for fetal ovary collection. For neonatal ovary collection, only the female 
pups were dissected after their birth at 19.5 dpc. 
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3.3.2. Histological Methods 
       Fetal and neonatal ovaries were dissected and trimmed of any extra tissue. They were 
fixed in Bouin’s solution for 2 hours at room temperature, followed by dehydration 
through an ethanol series.  Histological processing of the ovaries was performed at 
Electron Microscopy & Histology Core Facility, Weill Cornell Medical College, New 
York.	  Based on the standard protocols for paraffin-embedded sections, the ovaries were 
serially sectioned at 5 µm and stained with hematoxylin and eosin. Images were taken on 
an Olympus BX50 microscope with an Olympus DP71 digital camera. Every fifth section 
was marked for direct counts of oocytes at pre-diplotene and diplotene stages and at least 
five ovaries were analyzed at each age. A total of 10-12 sections per ovary were used for 
counting. To avoid bias, all ovaries were analyzed without knowledge of age.  To avoid 
double counting of oocytes, only oocytes having a visible nucleus were counted. Oocytes 
at the pre-diplotene stage were characterized at the leptotene stage by the speckled 
appearance of their nuclei, zygotene nuclei were be distinguished by their thicker 
chromosome strands and pachytene nuclei have chromosomes with a beaded appearance. 
Oocytes at the diplotene stage are recognized by areas of condensed chromatin 
interspersed with clear areas (Challoner, 1974). The total number of pre-diplotene and 
diplotene oocytes for each ovary was determined by multiplying the number of pre-
diplotene and diplotene oocytes by 5 to account for every 5th section being used in the 
analysis. Oocytes were counted as cysts if they were present in clusters of at least two 
oocytes without any intervening somatic cells. Oocytes were counted to be in primordial 
follicles if they contained an oocyte surrounded by flattened granulosa cells. 
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3.3.3. RNA isolation 
        Fetal (13.5 dpc-18.5 dpc) and neonatal (PND1-PND7) ovaries were dissected and 
stored in RNAlater at -80° C until further use. Total RNA was isolated using Qiagen’s 
RNeasy Mini kit (n=3; 50/ 100 ovaries per pool for neonatal and fetal ovaries 
respectively). Ovaries were briefly lysed and homogenized using a motor pestle and the 
mixture was then applied onto a QIAshredder column. The ovarian tissue sample in the 
QIAshredder column was then centrifuged at 11,000g for 2 minutes. To isolate the RNA, 
the resulting flow-through was applied to an RNeasy mini column which allowed the 
RNA to bind to the filter cartridge. RNA was eluted by washing from the filter and was 
concentrated using an RNeasy MinElute kit. The RNA which was isolated was briefly 
applied to an RNeasy MinElute spin column and after washing, RNA was eluted using 
14µl of RNase-free water. The RNA concentration in the elutant was determined using an 
ND-1000 Spectrophotometer (λ= 260/280 nm; Nanodrop Technologies, Inc., 
Wilmington, DE).  
 
3.3.4. First strand cDNA synthesis and real-time polymerase chain reaction (PCR) 
       Total RNA (0.5µg) was reverse transcribed using the Superscript III One-Step RT-
PCR System into cDNA. cDNA was diluted in RNase-free water (1:25). 2 µl of diluted 
cDNA was amplified on a Rotor-Gene 3000 using QuantitectTM SYBR Green PCR kit 
and custom designed primers for Msy2 (forward primer: 5' CCC TGG CAA CCA GGC 
GAC GG 3'; reverse primer: 5' TGA CTG TGC CCA GGA CTT GGA TTG 3'; NCBI 
Genbank accession number NM_016875), and β-actin (forward primer: 5´ AGT GTG 
ACG TTG ACA TCC GTA 3´; reverse primer: 5´ GCC AGA GCA GTA ATC TAA 
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TTA T 3´; NCBI Genbank accession number NM_007393). The cycling program 
consisted of a 15 min hold at 95°C and 45 cycles of: denaturing at 95°C for 15 s, 
annealing at 58°C for 15 s, and extension at 72°C for 20 s at which point data were 
acquired. Determination of product melt conditions were done using a temperature 
gradient from 72°C to 99°C with a 1°C increase at each step. β-actin expression remained 
constant across all ages and so each sample was normalized to β-actin before 
quantification.  
 
3.3.5. In vitro ovary organ culture  
       Ovaries dissected at 17.5 dpc were placed in culture. Ovaries were cultured in 4-well 
culture plates in drops of media on 0.4 µM floating filters (Millicell- CM; Millipore 
Corp., Bedford, MA) in 0.4 ml DMEM-Ham’s F-12 media supplemented with penicillin-
streptomycin, 5X ITS-X (Life Technologies, Inc., Grand Island, NY), 0.1 % BSA, 0.1% 
albumax, and 0.05 mg/ml L-ascorbic acid. E2 and P4 were purchased from Sigma 
Chemical Co., St. Louis, MO and dissolved in dimethylsulfoxide (DMSO) at a 
concentration of 0.1 M and then added to culture media to achieve the desired final 
concentration. DMSO was added to media at the same percent as the chemical to serve as 
vehicle control. Ovaries were placed in culture and exposed daily to E2, P4 or both 
hormones at 10-6 M or DMSO alone as a vehicle control (n= 5 ovaries per treatment 
group). The ovaries from control and treatment were fixed in Bouin’s fixative and 
histologically processed.  
 
 
73	  
	  
	  
	  
3.3.6. Statistical analysis 
       The percent of oocytes in diplotene, percent of oocytes in follicles and percent of 
follicles containing pre-diplotene oocytes over time were calculated using four to five 
ovaries at each time point. Data are represented as mean ± SEM of nontransformed data. 
Counted data by nature is not normal and logarithmic transformation was performed on 
the data before doing statistical analysis. Statistical analyses using transformed data were 
performed using GraphPad Prism version 6 (GraphPad Software, San Diego, CA). 
Statistical differences (P<0.05) among the means were evaluated using one-way ANOVA 
followed by Dunnett’s multiple comparison test. Effects of E2 and P4 on oocyte number, 
percent single oocytes, percent oocytes in diplotene and percent of follicles containing 
diplotene oocytes were analyzed in the same manner as the time course above using 5 
ovaries per treatment group. Statistical analyses of Real time PCR data were performed 
using Statview 5.0.1 (SAS Institute Inc., Cary, NC). Differences between fold increases 
in gene expression over various time points were evaluated by one-way ANOVA 
followed by Bonferroni-Dunn’s post hoc test (P< 0.0005). All results are presented as 
mean ± SEM of nontransformed data. 
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3.4. RESULTS 
3.4.1. Meiotic progression and diplotene arrest in developing mouse ovaries 
       Borum in 1961 reported that mouse oocytes begin to reach the diplotene stage at 17.5 
dpc (Borum, 1961). More recently, it has been reported that the first diplotene oocytes 
were observed at 18.5 dpc (Di Carlo et al., 2000). For that study, the sample size was 
limited to only 200 nuclei in ovaries of each age. In contrast, we did a thorough 
quantitative study counting histological sections for each timepoint from 15.5 dpc to 
PND5. This resulted in a consideration of approximately 1000 nuclei at each age. The 
earliest diplotene oocytes were observed at 17.5 dpc with about 8% of the oocytes at the 
diplotene stage (Figure 3.1A). A statistically significant increase to 32% diplotene 
oocytes was observed at PND1 and to 49% at PND2. No further increase was observed 
from PND3 to PND5. 
       Representative histological sections with examples of the different meiotic stages are 
shown in Figure 3.1C-3.1F. Figure 3.1C shows a section from a 13.5 dpc ovary with 
oogonia in mitosis characterized by dense nuclei and leptotene oocytes recognized by 
speckled appearance of their chromatin (Challoner, 1974; Yang and Fortune, 2008). 
Figure 3.1D shows a section from a 15.5 dpc ovary with oocytes at zygotene 
characterized thick strands of entangled chromatin (Challoner, 1974). Figure 3.1E shows 
a PND1 ovary with oocytes at pachytene distinguished by the beaded appearance of 
condensed chromatin (Challoner, 1974). Figure 3.1F shows a PND4 ovary with oocytes 
at diplotene characterized by areas of condensed chromatin separated by clear areas 
(Challoner, 1974). 
75	  
	  
	  
	  
       Mammalian female germ cells express a germ cell-specific Y-Box protein, MSY2, 
which is a cytoplasmic marker for diplotene oocytes. MSY2 is upregulated at the 
diplotene stage (Gu et al., 1998).	  In addition to the morphological assessment of meiotic 
stage discussed above, we also measured the levels of Msy2 mRNA by qPCR during the 
same time period (Figure 3.1B). A statistically significant increase of Msy2 mRNA is 
observed at 18.5 dpc correlating with the increase in diplotene oocytes observed one day 
earlier at 17.5 dpc.	  
	  
3.4.2. Primordial follicle formation and diplotene arrest are independent processes 
       Previous studies from our lab have indicated that in the medullary region, primordial 
follicles can be found as early as 17.5 dpc (Pepling et al., 2010). Here we performed a 
thorough investigation analyzing serial sections 5 µm apart covering the entire ovary 
thereby enabling us to obtain a more accurate estimate regarding the presence of 
primordial follicles. The earliest primordial follicles were detected at 16.5 dpc where we 
found 2% of the oocytes in enclosed in follicles (Figure 3.2A). An example of a 
primordial follicle in a 16.5 dpc ovary is shown in Figure 3.2C. We hypothesized that 
oocytes needed to reach diplotene before becoming enclosed in follicles. However, we 
observed follicles with pre-diplotene oocytes at all ages examined. Figure 3.2B shows 
the percentage of follicles containing pre-diplotene oocytes from 15.5 dpc to PND5. All 
of the follicles observed at 16.5 dpc were at the pre-diplotene stage. For the later stages, 
only a small percentage of follicles contained pre-diplotene oocytes with the majority 
already at diplotene. Figure 3.2D shows a 17.5 dpc ovary with a primordial follicle 
containing a pre-diplotene oocyte. We also observed oocytes still in germ cell cysts that 
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were at the diplotene stage (Figure 3.2E). Finally, at PND5 we observed a small 
proportion of pre-diplotene oocytes (Figure 3.2F). Thus, meiotic progression and 
primordial follicle formation do not appear to be linked. 
 
3.4.3. All oocytes in a cyst do not reach diplotene together 
       Oocytes enter meiosis in a wave from anterior to posterior in the mouse ovary. 
However, it is not known whether in individual cysts oocytes enter or progress through 
meiosis and arrest at diplotene synchronously. To determine whether all oocytes in a 
germ cell cyst were at the same meiotic stage, a quantitative analysis of the meiotic stages 
of the oocytes present within individual cysts was performed at 18.5 dpc. We chose this 
age this age because many pachytene and diplotene stage oocytes are present and most 
oocytes are still in germ cell cysts. We examined five representative cysts from five 
different ovaries labeled Cysts 1 - 5 shown in Figure 3.3. Each cyst contained two to five 
oocytes visible in the section. It is important to note that only oocytes in individual 
sections were analyzed and that the cysts likely contained more oocytes not visible in the 
section. For each cyst we determined whether an oocyte was at the pre-diplotene or 
diplotene stage of meiosis. Each cyst examined had both pre-diplotene and diplotene 
oocytes (Figure 3.3 and Table 3.1). These findings suggest that oocytes within 
individual cysts do not progress through meiosis synchronously. 
 
3.4.4. Progesterone decreases the number of follicles at diplotene 
       There is some evidence that steroid hormones can cause delays in meiotic 
progression. We wanted to know if E2 or P4 could delay arrival at the diplotene stage in 
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mouse ovaries. To test this, 17.5 dpc fetal ovaries were placed in organ culture for four 
days with control media or media containing 10-6 M E2, 10-6 M P4 or both 10-6 M E2 and 
10-6 M P4. After culture, serial sections were prepared, stained with hematoxylin and 
eosin and analyzed. There was no difference in the number of oocytes between control 
and treated ovaries (Figure 3.4A). There was also no difference in the percent of single 
oocytes, a measure of primordial follicle formation (Figure 3.4B). In addition, there was 
also no statistically significant difference in the percentage of oocytes at the diplotene 
stage of prophase I (Figure 3.4C). However, when only oocytes already assembled in 
primordial follicles were examined, there were significantly fewer follicles containing 
diplotene oocytes in the P4 treated ovaries (Figure 3.4D).  
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3.5. DISCUSSION 
       Here we investigated the relationship between two critical events in mammalian 
oogenesis, primordial follicle formation and diplotene arrest. We confirmed that the 
earliest diplotene oocytes were observed at 17.5 dpc and in accordance with this Msy2 
mRNA levels increase one day later. In previous studies from our lab the earliest age that 
primordial follicles were reported was 17.5 dpc (Pepling et al., 2010). However, here we 
observed a small percentage of follicles even earlier at 16.5 dpc. We also found 
primordial follicles containing pre-diplotene oocytes supporting the idea that oocytes do 
not need to reach diplotene arrest before they can become enclosed in primordial 
follicles. Furthermore, oocytes within individual germ cell cysts do not appear to proceed 
through meiosis synchronously. Finally, progesterone treatment delayed meiotic 
progression of oocytes in follicles. 
       There have been some reports that mouse oocytes arrest in the diplotene stage of 
meiosis I starting at 17.5 dpc while others do not observe diplotene oocytes until 18.5 dpc 
(Borum, 1961; Di Carlo et al., 2000). We reexamined this question and found oocytes at 
diplotene arrest as early as 17.5 dpc in agreement with the original studies of Borum. 
Further, we see an increase in the number of diplotene oocytes at PND1 and PND2 but 
surprisingly no further increase to PND5. Previous reports suggest that all oocytes have 
arrested in the diplotene stage by PND5. It may be that a small number of oocytes do not 
reach diplotene until later. 
       Inhibition of the synaptonemal complex protein SYCP1 in rats led to premature 
arrival of oocytes at the diplotene stage and also resulted in accelerated primordial 
follicle assembly (Paredes et al., 2005). These observations suggested that diplotene 
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arrest is developmentally linked with follicle formation in mice. However, our results 
here suggest that meiotic stage and primordial follicle formation are independent. Stra8 
deficient female mice have been previously shown to have	  meiotic initiation block at 13.5 
dpc to 14.5 dpc. (Baltus et al., 2006). The authors postulated that if oocyte growth and 
differentiation were required for meiotic entry then Stra8 deficient ovarian germ cells 
would not undergo folliculogenesis. Contrary to postulations, the germ cells in Stra8 
deficient ovaries did become enclosed in granulosa cells and develop to advanced stages 
(Dokshin et al., 2013). Thus, entry into meiosis or progression to the diplotene stage is 
not a prerequisite for oocytes to form follicles in mice. In cattle, however, the activation 
of primordial follicles to form primary follicles is correlated with the achievement of 
meiotic arrest by the oocyte (Yang and Fortune, 2008). 
       Here, we examined the effects of E2 and P4 on progression of oocytes to the 
diplotene stage. Surprisingly, P4 but not E2 delayed meiotic progression, decreasing the 
percent of follicles containing diplotene oocytes. In previous studies, exposure of 
pregnant C57BL/6 females to the estrogenic compound BPA, disrupted the processes of 
meiotic prophase (Susiarjo et al., 2007). Oocytes from female fetuses had defects in 
synapsis and increased recombination resulting in higher levels of aneuploidy. This may 
be due to differences in the specific time period examined or route of hormone exposure. 
BPA exposure was from 11.5 dpc until 18.5 dpc when the fetal ovaries were harvested 
while in our study 17.5 dpc ovaries were exposed to hormones in organ culture for 4 
days. There may also be differences depending on which estrogenic compound is used. 
Finally, Susiarjo and colleagues examined chromosomal defects while we examined 
progression to the diplotene stage. 
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       Previous work from our lab demonstrated that exposure to P4 or E2, as well as 
synthetic estrogens, BPA, diethylstilbestrol or ethinyl estradiol delays germ cell cyst 
breakdown and primordial follicle formation (Chen et al., 2007; Karavan and Pepling, 
2012). In addition, synthetic estrogens at some concentrations also alter the oocyte loss 
that accompanies cyst breakdown. Here we found that P4 or E2 had no effect on cyst 
breakdown, primordial follicle formation or oocyte survival. The previous studies began 
hormone exposure at PND1 while in the current work hormone treatment began earlier at 
17.5 dpc and this maybe outside the window of sensitivity. Interestingly, in a previous 
study using rats P4 but not E2 significantly inhibited primordial follicle assembly (Kezele 
and Skinner, 2003). While in our study neither hormone affected follicle assembly we 
also observed an effect with P4 not on follicle formation but on meiotic progression. 
       In summary, the processes of primordial follicle formation and meiotic progression 
to the diplotene stage do not appear to be linked. P4 reduced the percent of oocytes within 
primordial follicles that had reached diplotene arrest. Diplotene arrested oocytes often 
remain dormant for many years before being activated. Mechanisms controlling 
progression of oocytes through prophase I and arrest at diplotene are not well understood 
but this knowledge will be essential to prevent defects in meiosis such as aneuploidy. 
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3.6. Table 
 
 
 
 
Table 3.1. Analysis of meiotic stage within 5 individual germ cell cysts 
Cyst # of oocytes at 
pre-diplotene 
# of oocytes at  
diplotene 
Total # of oocytes  
Cyst 1 4 1 5 
Cyst 2 1 2 3 
Cyst 3 1 1 2 
Cyst 4 1 1 2 
Cyst 5 2 3 5 
Total 9 8 17 
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3.7. Figures 
 
	  
 
 
Figure 3.1. Diplotene oocytes first detected at 17.5 dpc.  (A) Percentage of oocytes at 
the diplotene stage meiotic prophase I (± SEM) in perinatal mouse ovaries from 15.5 dpc 
to PND5. Asterisks indicate a significant difference (P < 0.05; n=4-5 ovaries per time 
point) as determined by one-way ANOVA followed by Dunnett’s Multiple Comparison 
Test. (B) Relative measurements of mRNA corresponding to MSY2, a specific marker 
for diplotene stage oocytes as determined by qPCR in perinatal mice ovaries at different 
gestational ages. The levels of MSY2 mRNA are normalized to the levels of mRNA for a 
housekeeping gene, β-actin in the same sample. Asterisks indicate a significant difference 
(P<0.0005) as determined by one- way ANOVA with Bonferroni-Dunn’s post hoc test 
(n=3). (C-F) Representative histological images of perinatal mouse ovaries stained with 
hematoxylin and eosin showing different meiotic stages. (C) 13.5 dpc ovary showing 
oogonia in mitosis and oocytes at leptotene. (D) 15.5 dpc ovary showing oocytes at 
zygotene. (E) PND1 ovary showing oocytes at pachytene. (F) PND4 ovary showing 
oocytes at diplotene. Scale bar = 50 µM. 
Leptotene 
Mitosis 
C) 13.5 dpc 
Zygotene 
D) 15.5 dpc 
E) PND1 
Pachytene 
F) PND4 
Diplotene 
A
)
B
)
83	  
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Follicle formation and meiotic progression in perinatal mouse ovaries.  
(A) Percentage of oocytes in follicles (± SEM) over time. Different letters indicate a 
significant difference between groups (one-way ANOVA, P<0.05). (B) Percentage of 
follicles at the pre-diplotene stage out of total follicles (± SEM) in perinatal mice ovaries. 
Asterisks indicate a significant difference (P< 0.05; n=4-5 ovaries per time point) as 
determined by one-way ANOVA followed by Dunnett’s Multiple Comparison Test. (C-
F) Representative histological images of perinatal mouse ovaries stained with 
hematoxylin and eosin. (C) 16.5 dpc ovary showing a primordial follicle with a pre-
diplotene oocyte indicated by an arrow. (D) 17.5 dpc ovary showing a primordial follicle 
containing a pre-diplotene oocyte indicated by an arrow. (E) PND3 ovary showing 
diplotene oocytes not yet enclosed in primordial follicles. (F) PND5 ovary showing a pre-
diplotene oocyte. Scale bar = 50 µM. 
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Figure 3.3. Representative histological images showing paraffin sections of fetal 
mouse ovaries at 18.5 dpc stained with hematoxylin and eosin.  
(A) ovarian section showing one cyst labeled Cyst 1 with five oocytes, one oocyte in 
diplotene and four in pre-diplotene. (B) ovarian section showing one cyst labeled Cyst 2 
with three oocytes, two in diplotene and one in pre-diplotene. (C) ovarian section 
showing Cyst 3 with two oocytes, one in diplotene and one in pre-diplotene (D) ovarian 
section showing one cyst labeled Cyst 5 with five oocytes three in diplotene and two in 
prediplotene. Diplotene oocytes are indicated by an arrow and pre-diplotene oocytes are 
indicated by an arrowhead. Scale bar = 20 µM. 
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Figure 3.4. Effects of E2 and P4 treatment in organ culture on meiotic stage. 
 (A) Total number of oocytes, (B) percent single oocytes (C) percent of diplotene oocytes 
and (D) percent of follicles containing diplotene stage oocytes in control ovaries or 
ovaries treated with 10-6 M E2, 10-6 M P4 or 10-6 M E2 + 10-6 M P4 for 4 days in organ 
culture. Data are presented as the mean ± SEM. * indicates a significant difference (P < 
0.05; n=5 ovaries per treatment) as determined by one-way ANOVA followed by 
Dunnett’s Multiple Comparison Test. 
co
nt
ro
l
10
-6
 M 
E2
10
-6  M
 P4
10
-6  M
 E2
 + 
P4
0
1000
2000
3000
4000
# 
o
f o
o
cy
te
s
co
nt
ro
l
10
-6  M
 E2
10
-6  M
 P4
10
-6  M
 E2
 + 
P4
0
10
20
30
40
50
%
 o
f o
o
cy
te
s 
in
 d
ip
lo
te
n
e
A)  
C)  
	  B)  
	  D)  
	  
86	  
	  
	  
	  
 
 
 
 
 
 
Chapter 4 
Conclusions and Future Directions 
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4.1. Conclusions 
       The overarching theme of this dissertation is to elucidate the sources of steroid 
hormones in perinatal ovaries and  investigate  their  role on meiotic progression. Fertility 
and reproductive lifespan of a female mammal is limited to the germ cell reserve present 
at the time of birth (Kezele et al., 2002). A  lot remains elusive about  the signaling 
pathways responsible for maintaining the early germ cell reserve as well as  factors 
causing germ cell apoptosis. It has been observed that in higher mammals like cattle, fetal 
oogenesis is regulated by the autocrine and paracrine actions of the hormones produced 
by the fetal ovaries themselves (Nilsson and Skinner, 2009; Yang and Fortune, 2008). We 
sought to determine whether the same phenomenon occurs in perinatal mice ovaries. We 
first measured the circulating maternal E2 and P4 levels during gestation. E2 levels were 
considerably low during 13.5dpc to 15.5 dpc when cysts are being actively formed. This 
suggests that maternal E2 did not play any role in maintaining oocytes in cysts in the fetal 
ovaries. Additionally, the earliest primordial follicles were detected at 16.5 dpc by the 
present studies. The circulating maternal P4 level is highest at this time-point and  it drops 
after that. The maternal circulating level of E2 did not seem to play a role in maintaining 
oocytes in cysts in the fetal ovaries. We then sought to explore the possibility of perinatal 
ovaries synthesizing steroid hormones. The presence of steroidogenic enzymes, 
aromatase and 3βHSD (both  mRNA and protein), were confirmed in the perinatal 
ovaries. The intraovarian steroid content of the perinatal ovaries were examined by RIA. 
E2 levels were highest in the fetal ovaries at 17.5 dpc and then decreased and became 
undetectable at birth. The levels of P4 on the other hand did not vary much from 15.5 dpc 
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to PND3. The intraovarian steroid hormone levels detected here seem to correlate well 
with studies done with neonatal ovaries in other rodents like hamsters. In hamsters, a 
basal level of E2 is found to be essential for normal primordial follicle development and 
somatic cell differentation (Wang and Roy, 2007). The authors also conclude from their 
observations that it is the dosage of the steroid hormones rather than their presence which 
determines whether it has a inhibitory or supportive role in follicle formation (Wang and 
Roy, 2007). During fetal oogenesis in humans, apoptosis of oocytes decreases 
considerably when the maternal and fetal E2 levels begin to rise from  22 weeks of 
gestation (Casey, 1998; Shutt et al., 1974; Vaskivuo et al., 2001). We conjecture from our 
findings  that the  low levels of steroid hormones found in the perinatal mice ovaries help 
to support the healthy development of primordial follicles during that period. 
       We then treated fetal ovaries at 16.5 dpc in organ culture for five days with 
aromatase and 3βHSD inhibitors (letrozole and trilostane respectively) and collected 
them at PND3. We found that the treated ovaries have significantly fewer oocytes per 
section compared to control (untreated). This is in accordance to what is found in ArKO 
mice which have significantly fewer number of primordial and primary follicles 
compared to the wildtype mice aged 10 weeks (Britt et al., 2004). This underscores the 
importance of E2 and P4 in early follicle formation. Our findings with the  in vitro 
inhibitor experiments during the perinatal period extend our understanding regarding the 
low follicle count found at puberty in ArKO mice. The ArKO mice are deficient in E2 
and this deficit might account for the fewer  number of oocytes to begin with during the 
neonatal development which results in the reduced follicle count in the pubertal ovary. 
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       A similar phenomenon occurs in higher mammals like baboons. In one particular 
study, pregnant baboons were treated with aromatase inhibitor and ovaries from the 
female fetuses of those pregnant dams were analyzed (Zachos et al., 2002). On analysis, 
it was found that fetal ovaries from the pregnant dams who were deprived of E2 by 
inhibitor treatment have their primordial follicle count reduced by 50 %  compared to 
fetuses from untreated dams (Zachos et al., 2002). The fetuses from pregnant dams who 
were treated with inhibitor plus estradiol benzoate and have their E2 levels restored to 
about 30 % of normal levels have a follicle count similar to controls (untreated 
fetuses)(Zachos et al., 2002). Collectively, these findings emphasize a critical role of E2 
in maintaining the oocyte pool during the perinatal period in higher mammals. 
       In Chapter 3, we sought to examine the role of steroid hormones in the meiotic 
progression of oogenesis. There are two arrests during  meiosis in mammalian oogenesis, 
diplotene arrest and metaphase II arrest during meiois II. Diplotene arrest primarily 
occurs around the time of primordial follicle formation. There was no definitive evidence 
till date to link the two temporally occuring events. We did a thorough quantitative 
analysis to examine the possibility of a  link between the two processes and categorized 
the oocytes into four classes while counting in cysts at pre-diplotene, in cysts at 
diplotene, in follicles at pre-diplotene and in follicles at diplotene. A significant finding 
was that primordial follicles are observed as early as 16.5 dpc. The oocytes begin to enter 
diplotene from 17.5 dpc onwards. This underscores the fact that primordial follicle 
formation is not dependent on the diplotene stage of oocyte nuclei. Our counting data 
correlate well with observations in Stra8- mice. Stra8 is essential for meiotic entry of 
oocytes and thus germ cells in ovaries of Stra8-  mice are observed to have a block in 
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meiotic entry at 13.5 dpc  to 14.5 dpc (Baltus et al., 2006).  It was observed that the germ 
cells continue to grow and differentiate to form follicles in a manner consistent with 
normal follicle development (Dokshin et al., 2013). Collectively, these observations 
reinforce the fact that primordial follicle formation in mice does  not depend on the 
meiotic stage of the oocyte nuclei.  
       Germ cell meiosis is a critical event during mammalian oogenesis and any 
aberrations in this process can lead to aneploid eggs. Xenoestrogens, like BPA in 
particular have been shown by various studies to cause various meiotic prophase defects 
(Susiarjo et al., 2007). Our second objective was to examine the effects of E2 and P4 on 
meiotic progression of oocytes. To test this, ovaries at 17.5 dpc were cultured for four 
days and collected at PND3 in three separate experimental sets  treated with (10-6M E2, 
10-6M P4 and 10-6M E2 & P4). Only P4 had an effect in decreasing the percent of diplotene 
follicles from 66% in control ovaries to 45.6% in P4 treated ovaries (P< 0.05). In cattle,	  
both E2 and P4 had an effect in reducing the number of primary follicles at diplotene stage 
by 90% and 85%, respectively (Yang and Fortune, 2008).  
          A critical factor which governs the fertility of a female mammal at puberty is the 
finite pool of primordial follicles formed during the perinatal period (Kezele et al., 2002).  
Infertility has been recognized as a public health concern by the  World Health 
Organization (WHO). According to the report of a survery done from 2006-2010 by 
National Survey of Family Growth, CDC about 7.4 million women or 11.9% of women 
in the population have sought infertility treatments at some point during their 
reproductive life span. The delay in the maternal age of childbearing and exposure to 
environmental toxins are particularly held responsible in decreasing the follicle count in 
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the ovaries leading to infertility. The two predominant disorders which interferes with the 
formation of healthy follicles and ovulation in women are premature ovarian failure or 
primary ovarian insufficiency when the ovaries fail to respond to circulating FSH by 
synthesizing E2 and develop mature follicles and  primary amenorrhea which is the 
absence of menstruation. (Coulam et al., 1986; Yen, 1991). Studies in this dissertation 
have primarily addressed the role of steroid hormone signaling which plays a critical role 
in the formation of the reservoir of primordial follicles. For advanced reproductive 
technologies like in vitro fertilization (IVF), live birth from donor embryo transfer, it is 
important to maintain the reservoir of healthy follicles for ovulation. While this 
dissertation study addresses basic mechanisms in the formation of primordial follicles 
during the perinatal period, translational implications are enormous. 
   
4.2. Future Directions 
          An interesting area to explore for future research is to examine whether placenta, 
which remains intimately associated with fetal growth and metabolism, might have an 
effect on the formation of follicles in the fetal ovary. The placenta is the site of synthesis 
for  various hormones like chorionic gonadotropin, estrogen and progesterone. Estriol is 
the predominant estrogen produced during pregnancy by the placenta. It would be helpful 
to collect the placenta particularly during the time period of 13.5 dpc to 15.5 dpc when 
cysts are being formed. A timecourse of placental hormone levels (mainly estriol and 
progesterone) might be useful to address whether placental hormones play a role in 
oocyte development in fetal ovaries. 
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      In Chapter 2, we analyzed the intraovarian steroid content of the perinatal ovaries. A 
more direct approach would be to cultivate the perinatal ovaries in organ culture and 
collect the media for hormone assays. Our initial attempts to grow the ovaries in vitro for 
a few days and collect the media for hormone assays  proved unsuccessful. The hormone 
content of the media was below the detection limit of RIA. There are several ways to 
circumvent the problem. One ideal way would be to concentrate the media by changing 
only half of the volume (e.g. 200 µl) of the total 400µl volume 
daily with  fresh media. In that way, half of the old media would already have the 
hormones secreted by the ovaries and the other half of the fresh media would provide 
sufficient fresh nutrients to support growth of the ovaries. Another way is to increase the 
number of ovaries grown on each filterpaper in order to increase the amount of steroid 
hormones secreted in the media. In our present organ culture protocol , we usually 
cultivate 3-4 ovaries per filterpaper. An ideal way would be to do a trial set with 4, 6, 8 
and 12 ovaries per filterpaper. Plotting the amount of hormone secreted in the media (Y 
axis) vs. the number of ovaries placed in each filterpaper (X axis) would ideally give rise 
to an exponential curve. The point where the curve becomes a plateau is where the 
number of ovaries per filterpaper has exceeded the optimal number of ovaries such that 
feedback inhibition on the hormone secretion occurs. Ideally, the optimal number of 
ovaries to be placed in the filterpaper would be a number in the exponential region of the 
curve. 
       In this dissertation study,  in vitro inhibitor studies in organ culture were carried out 
with letrozole and trilostane to block aromatase and 3βHSD action respectively.  The 
earliest age at which the ovaries of ArKO mice have been analyzed is 10 weeks (Britt et 
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al., 2004). They have fewer number of follicles developing in their ovaries compared to 
age-matched wildtype females (Britt et al., 2004). An interesting area for future research 
would be to collect neonatal ovaries of three possible genotypes by mating ArKO 
hetrozygotes (+/-) parents. The three expected genotypes of the offsprings would be  
wildtype (+/+), heterozygote (+/-) and homozygous knockout (-/-). In heterozygous (+/-) 
ovaries, with one copy of the aromatase gene it is predicted to have half the amount of E2 
synthesis as opposed to wildtype (+/+) ovaries. Whereas, in homozygous knockout (-/-) 
ovaries, lacking both the copies of aromatase gene, there would be no E2 synthesis . It 
would be useful to grow the ovaries of three expected genotypes in organ culture media 
for a few days and  analyze the percent of cyst breakdown of each genotype. This would 
enable us to derive a comparative estimate of the role of  50% E2 synthesis in perinatal 
ovaries of  heterozygotes (+/-) as opposed to total absence of E2 synthesis in homozygous 
knockouts (-/-) and also 100% E2 synthesis in wildtype (+/+). In  in vitro  conditions, it 
would also be possible to grow perinatal ovaries of homozygous knockouts (-/-) in 
presence of exogenous E2 treatment. By comparing the results of percent of cyst 
breakdown from such exogenous E2 treatment in (-/-) ovaries to the percent of cyst 
breakdown  in wildtype or heterozygote ovaries- would enable us to get better insights 
about the role of  E2 synthesis during perinatal mice oogenesis.  Also, it would help to 
extend our understandings of our previous in vitro inhibitor results. 
       Another interesting direction to consider for future research might be to gain better 
insights whether estradiol and progesterone have any effects in inhibiting cyst breakdown 
when the ovaries are treated during the fetal period. In Chapter 3, we treated the ovaries 
as early as 16.5 dpc with E2 and P4 and grew  them for five days to be collected at PND3. 
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Our main objective was to examine whether the hormone treatment had any effect on 
diplotene arrest of the oocytes. It was indeed surprising to observe though hormonal 
treatment (only P4) reduced the number of primordial follicles at diplotene, both E2 and 
P4 had no effect in inhibiting cyst breakdown during that period. Our previous findings 
(Chen et al., 2007) clearly demonstrate an inhibitory effect of E2 and P4 on cyst 
breakdown thus reducing the total number of primordial follicles when treated from 
PND1 to PND7. This apparently contradictory report might require more detailed 
examination whether hormonal treatments have effects in inhibiting when treated only 
during a specific time-frame. Overall, this dissertation study has contributed in opening 
several interesting avenues to pursue for future research. 
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